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Abstract 
The nervous system consists of billions of neurons interconnected through 
specialized connections known as synapses. When and where these synapses 
form determines the functionality of the nervous system, and abnormal synaptic 
development has been linked to a variety of disorders such as autism and 
epilepsy. In addition, understanding how synapses are formed could lead to 
treatments for a variety of conditions characterized by a loss of synaptic 
connectivity, including Alzheimer’s disease and stroke. Therefore, understanding 
the molecular processes that regulate the formation of synapses has become a 
major goal of modern neuroscience research.  
 To form a synapse, a neuron must grow an axon, guide that axon to its 
proper target, and then form a synaptic connection. All of these processes must 
be coordinated to ensure synapses form at the correct time and in the correct 
location. One family of proteins that has become viewed as candidates to 
mediate this coordination is the Pam/Highwire/Rpm-1 (PHR) protein family. Over 
the past decade, the PHR proteins have emerged as key regulators of axon 
outgrowth and guidance, synapse formation, and degeneration. Given their 
central role in neurodevelopment, the discovery of any additional components of 
PHR signaling has the potential to increase our understanding of how a synapse 
is made, as well as identify therapeutic targets for pharmaceutical intervention. In 
the following dissertation, I outline two studies focused on the C. elegans PHR 
protein RPM-1 and the identification of novel mediators of RPM-1 signaling. In 
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the first study, I provide evidence that the PP2C phosphatase PPM-1 functions 
as a second regulatory mechanism to RPM-1 to negatively regulate a MAP 
kinase cascade. This study provides insight into the regulation of MAP kinase 
signaling in neurons, as well as a new role for PP2C phosphatases in neural 
development. In the second study, I identify the nuclear anchorage protein ANC-
1 as a novel binding partner of RPM-1. My genetic data also indicates that ANC-
1 functions through the -catenin BAR-1 to regulate neurodevelopment. Our 
study highlights a new mechanism by which RPM-1 functions, as well as the first 
genetic link between RPM-1 and a pathway that is regulated by extracellular 
signals, such as Wnts. 
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1 Introduction 
 
1.1 Overview of synapse formation 
 
The complexity of the human nervous system is staggering. The brain contains 
trillions of neurons, each forming as many as a thousand connections with other 
neurons in a precise pattern that is essential for proper function. Understanding 
how these connections, known as synapses, form is of great importance 
clinically, as abnormal circuit development has been linked to a variety of 
disorders including autism, anxiety, and epilepsy (Leonardo and Hen, 2008; 
Betancur et al., 2009). In addition to its role during development, synapse 
formation also appears to be important in the action of some antidepressants (Li 
et al., 2010), as well as memory storage (Kleim et al., 2002). Furthermore, 
understanding what molecules can promote the formation of synapses could lead 
to treatments for a number of neurodegenerative diseases such as Alzheimer’s 
disease, in which a great number of synapses are lost. These are just a few 
examples of why a major goal of neuroscience research is to discover the cellular 
and molecular processes that govern and guide the creation of a nervous 
system. 
A functioning nervous system is dependent on the creation of synapses. 
Synapses are structures that permit a neuron to pass an electrical or chemical 
signal to another cell (neuron, muscle, or gland). Chemical synapses are 
composed of both a pre- and postsynaptic terminal that is separated by a 
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synaptic cleft. The presynaptic terminal is composed of two main regions: the 
electron dense “active zone” and a pool of synaptic vesicles that surrounds the 
active zone.  
The active zone is the region of synaptic vesicle fusion and 
neurotransmitter release (Couteaux and Pecot-Dechavassine, 1970). Proteins 
such as RIM, Munc13, RIM-BP, -liprin and ELKS are some of the many proteins 
which function to dock synaptic vesicles and initiate the release of 
neurotransmitters into the synaptic cleft (reviewed in Sudhof, 2012). In the 
synaptic vesicle pool, vesicles are loaded with neurotransmitters and await 
docking and fusion (reviewed in Rizzoli and Betz, 2005). The postsynaptic 
terminal contains receptors for the neurotransmitters, as well as other molecules 
such as ion channels that are required for a response in the postsynaptic cell.  
 In order to form a synapse, a neuron must extend an axon out towards its 
target. As the axon migrates, it is directed by extracellular guidance cues. These 
cues can either be secreted or membrane bound and include molecules such as 
Netrins (Kennedy, 2000), Slits (Brose and Tessier-Lavigne, 2000), semaphorins 
(Pasterkamp and Kolodkin, 2003) and Ephrins (Kullander and Klein, 2002). The 
guidance cues are detected by a specialized structure at the tip of the developing 
axon called the growth cone, a filamentous (F) actin rich structure coated in 
receptors for the guidance cues. Guidance cues can either be attractive or 
repulsive, and when guidance cues interact with their specific receptor they 
initiate localized intracellular signaling cascades. It is the asymmetric activation of 
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these signaling cascades that leads to localized cytoskeleton modifications, 
thereby navigating the axon towards its specific target (Dickson, 2002). 
 Once the axon reaches its target, a synapse can then be formed. While 
numerous molecules are known to be required for synapse formation, the 
mechanisms by which many of them function are just beginning to be 
understood. Various cell adhesion molecules have been proposed to act as 
major players in triggering synapse formation. For example, neuroligins and their 
binding partners, the neurexins, have been shown to induce the formation of 
presynaptic terminals on non-neuronal cells (Scheiffele et al., 2000; Fu et al., 
2003). It was further established that each partner can form a hemisynapse; 
neuroligins trigger presynaptic differentiation and neurexins trigger postsynaptic 
differentiation (reviewed in Craig and Kang, 2007). In addition, N-cadherins are 
found in both pre- and postsynaptic terminals and are found to accumulate prior 
to differentiation of the terminal, as well as function in the recruitment of synaptic 
components (Fannon and Colman, 1996; Togashi et al., 2002; Takeichi, 2007). 
Disruption of cadherin based contact also inhibits the formation of synapses in 
hippocampal cell cultures (Togashi et al., 2002; Bozdagi et al., 2004). 
 Creating proper synaptic connections requires precise axon navigation, as 
well a coordinated switch between axon growth and the formation of synapses. 
While they are often studied independently, axon guidance, outgrowth, and 
synapse formation are all interrelated processes that occur during the 
development of the nervous system. This is supported by evidence that guidance 
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cues, adhesion molecules, and various morphogens can function in both axon 
outgrowth as well as synapse formation (Shen and Cowan, 2010). The focus of 
this dissertation is the characterization of two molecules and their novel role in 
regulating this developmental coordination.    
 
1.2 C. elegans as a model to study neurodevelopment 
 
C. elegans is a free-living microscopic nematode found in temperate soil 
environments. Its small size, short lifespan, transparent body, and the availability 
of numerous genetic tools has made it a popular genetic system (Brenner, 1974). 
Detailed studies have precisely mapped the nervous system of C. elegans, 
revealing that it is relatively simple at only 302 neurons, and that the positioning 
of these neurons is invariant (White, 1986). In addition, the vast majority of the 
known molecules that regulate C. elegans neurodevelopment are conserved in 
higher organisms (Margeta et al., 2008). Taken together, these features have 
made C. elegans an excellent model system in which to study the development 
of the nervous system. In this dissertation, I will highlight two specific areas of the 
C. elegans nervous system that will be used to study synapse formation as well 
as axon outgrowth: the GABAergic neuromuscular junctions and the soft-touch 
mechanosensory neurons. 
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1.3 C. elegans GABAergic synapses  
 
In C. elegans the GABAergic nervous system consists of 26 neurons. Of these 
neurons, the VD and DD subsets of motorneurons are required for movement 
(McIntire et al., 1993). The VD and DD motor neurons innervate the ventral and 
dorsal body wall muscles, respectively, and form multiple synapses along the 
length of their axons. These synapses are referred to as synapse en passant and 
are morphologically similar to GABAergic and glutamatergic synapses found in 
the vertebrate CNS. Activation of the VD or DD motorneurons leads to the 
release of GABA, causing relaxation of the body wall muscles. The release of 
GABA is coordinated with excitatory output on the opposing side of the worm, 
resulting in the sinusoidal movement of C. elegans. 
 With the development of Green Fluorescent Protein (GFP) markers, it has 
become possible to observe synaptic vesicle proteins in living animals (Chalfie et 
al., 1994). Specifically, the construction of synaptobrevin::GFP (SNB-1::GFP) by 
M. Nonet allowed for the visualization of synaptic terminals in live C. elegans 
(Nonet, 1999). By driving SNB-1::GFP expression with a GABAergic motor 
neuron specific promoter (unc-25), the presynaptic terminals of the VD and DD 
motorneurons can be observed. This transgene, Punc-25SNB-1::GFP, also known 
as juIs1, exhibits uniformly shaped puncta evenly distributed along the length of 
the ventral and dorsal nerve cords (Jin et al., 1999) (Figure 1-1). In forward 
genetic screens, juIs1 has been a useful tool in identifying mutants with abnormal 
presynaptic terminals, such as syd-2 (Zhen and Jin, 1999) and rpm-1 (Zhen et 
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al., 2000).  juIs1 has also been used to characterize new regulators of synapse 
formation such as fsn-1 (Liao et al., 2004) and glo-4 (Grill et al., 2007). 
 
1.4 C. elegans mechanosensory neurons 
 
In order to sense soft touch, C. elegans relies on six touch receptor neurons. 
These neurons, known as the mechanosensory neurons, extend long 
microtubule filled processes that span a large portion of the animal (Chalfie and 
Thomson, 1979). Upon activation, the mechanosensory neurons function in a 
variety of behaviors, including locomotion, feeding, and mating. 
 
 
Figure 1-1 C. elegans VD and DD Motorneurons. 
Schematic of D-motor neuron wiring. VD motor neurons receive input from the dorsal 
excitatory neurons and release GABA onto ventral body wall muscles. DD motor neurons 
receive input from ventral excitatory neurons and release GABA onto dorsal body wall 
muscles. The presynaptic terminals of these neurons can be visualized using the transgene 
juIs1(Punc-25SNB-1::GFP) (upper image). 
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 Due to their morphology and location, the mechanosensory neurons make 
an excellent system in which to study axon outgrowth and targeting. Specifically, 
two sets of neurons, the ALM and PLM neurons, extend a long single process 
that terminates its growth at a precise anatomical location (Figure 1-2). By using 
a transgenic marker that specifically labels the worm mechanosensory neurons, 
muIs32 (Pmec-7GFP), mutants can easily be examined for any ALM or PLM 
targeting or termination abnormalities.  
 
 
1.5 The PHR proteins 
 
Recently, one family of proteins that has emerged as key regulators of axon 
guidance and outgrowth as well as synapse formation is the Pam/Highwire/RPM-
1 (PHR) protein family. The PHR protein family was initially founded with the 
discovery of human Protein Associated with Myc (Pam) (Guo et al., 1998). Since 
then, the family has been expanded to include members such as mouse Phr1, 
 
 
Figure 1-2 C. elegans mechanosensory system. 
The soft touch response is mediated by six touch receptor neurons (2ALM, 2PLM, AVM, 
PVM). Each neuron extends a long, microtubule containing process along the length of the 
animal  
   8 
zebrafish esrom, Drosophila Highwire, and C. elegans RPM-1. A role for PHR 
proteins in neurodevelopment first emerged from genetic screens in C. elegans 
(Schaefer et al., 2000; Zhen et al., 2000) and Drosophila (Wan et al., 2000) 
looking for mutants with abnormal synapse morphology. In C. elegans rpm-1 
mutants, some neurons overgrow while others display atypical synapse 
morphology. RPM-1 has also been shown to affect axon regeneration. rpm-1 
mutants show enhanced regeneration of motorneuron axons after axotomy, while 
overexpression of RPM-1 inhibits axon regeneration (Hammarlund et al., 2009; 
Nix et al., 2011). Drosophila Highwire mutants display an increased number of 
axon branches with higher numbers of presynaptic terminals. Highwire mutants 
also show improved regeneration and inhibition of axonal degradation following 
injury (Xiong et al., 2010; Xiong et al., 2012). 
In vertebrates, PHR proteins have also been shown to play a large role in 
axon guidance. In Zebrafish esrom mutants, axons in the retina fail to target to 
the posterior and instead arborize ectopically (D'Souza et al., 2005). In Phr1 
knockout mice, the phrenic nerve no longer completely innervates the diaphragm 
(Burgess et al., 2004). Phr1 knockouts also display axon guidance defects with a 
reduction of axon tracts in the CNS and a reduction of neurites in the cerebral 
cortex (Bloom et al., 2007). Similar to Highwire, loss of Phr1 also results in 
prolonged survival of injured axons (Babetto et al., 2013). 
In invertebrates, PHR expression is limited to the nervous system. In 
vertebrates, however, PHRs are not as restricted. Pam transcripts are found in 
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many tissues but are most prevalent in the brain and thymus (Guo et al., 1998). 
Zebrafish esrom is also widely expressed in both neuronal and non-neuronal 
cells (D'Souza et al., 2005). Unlike their invertebrate counterparts, Phr1 and 
esrom are required for viability (Karlstrom et al., 1996; Burgess et al., 2004). 
While PHR mutants exhibit a diverse range of phenotypes; axon guidance, 
axon outgrowth, and synapse formation are all interrelated events that must be 
coordinated during development. Thus, a common theme in PHR mutants may 
be that neurons fail to transition properly between these various stages of growth 
(Po et al., 2010). This could lead to a variety of phenotypes, such as axon 
overgrowth or undergrowth, axon oversprouting, and underdeveloped or 
overgrown synapses, all depending on the cell type and the surrounding 
extracellular cues. 
 
1.6 PHR protein signaling 
 
The involvement of PHR proteins in so many different processes is likely due to 
their large size and the presence of multiple conserved domains (reviewed in Po 
et al., 2010)). PHR proteins contain an RCC1 like domain with inferred guanine 
exchange activity, dual PHR protein specific repeats, a Myc binding domain (in 
vertebrates), a RING H2 zinc finger domain (a motif indicative of E3 ubiquitin 
ligase activity) (Guo et al., 1998; Wan et al., 2000; Zhen et al., 2000), and a 
recently identified RAE-1 binding domain (Grill et al., 2012) (Figure 1-3A). 
Through these domains, the PHRs function in multiple signaling pathways. 
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Studies in C. elegans, Drosophila, and mice have shown PHR proteins function 
as E3 ubiquitin ligases that negatively regulate p38 and JNK MAP kinase 
cascades (Nakata et al., 2005; Collins et al., 2006; Lewcock et al., 2007). 
Mammalian PHRs also regulate mTOR signaling by ubiquitinating the Tuberous 
Sclerosis Complex (Han et al., 2008; Han et al., 2012b). Besides acting as an 
ubiquitin ligase, other PHR protein signaling partners include adenylate cyclase 
(Scholich et al., 2001), myc (Guo et al., 1998), a Rab GEF GLO-4 (Grill et al., 
2007), microtubule binding protein RAE-1 (Grill et al., 2012) and a neuronal K+ 
Cl- transporter KCC2 (Garbarini and Delpire, 2008). 
   11 
 
 
 
Based on the importance PHR proteins play in regulating 
neurodevelopment, finding additional molecules that function in their signaling 
pathways is an important step in learning how synapses are made. While the list 
of interacting proteins is already large, biochemical and genetic evidence 
suggests that there are still more molecules to be discovered and characterized. 
 
 
 
Figure 1-3 The PHR Proteins 
(A) Diagram of conserved domains in the PHR family members Pam, Highwire, and RPM-1. 
RLD: RCC1 like domain. PHR: PHR repeats. RBD: Rae-1 binding region. MBD: Myc binding 
domain. RING: RING-H2 finger domain. (B) RPM-1 functions through multiple signaling 
pathways to regulate neurodevelopment. It is a positive regulator of the glo-4 pathway, 
consisting of the Guanine Nucleotide Exchange Factor (GEF) GLO-4 and the Rab GTPase 
GLO-1. RPM-1 also forms an Skip-Cullin-F-box (SCF) ubiquitin ligase complex with the F-box 
protein FSN-1, which negatively regulates a p38 MAPK cascade.  
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To find these additional players, I have focused my work on the C. elegans PHR 
protein RPM-1. 
 
1.7 C. elegans RPM-1 
 
The C. elegans PHR protein, Regulator of Presynaptic Morphology (RPM)-1, was 
first identified in screens for mutants with synaptic and axon morphology defects 
(Schaefer et al., 2000; Zhen et al., 2000). In rpm-1 loss of function (lf) mutants, 
synapses viewed with the transgene juIs1 showed a disorganized appearance, 
with some regions of the dorsal cord containing no visible transgene, while others 
possess large accumulations of synapses (Zhen et al., 2000). Schaefer et. al. 
concurrently showed that mechanosensory neuron synapses were also 
abnormally patterned. Additionally, using the muIs32 transgene, they showed 
that the morphology of the mechanosensory neurons was abnormal, with the 
axons of the ALM and PLM neurons routinely growing past their normal 
termination points.   
 RPM-1 is known to regulate neurodevelopment through a number of 
signaling pathways (Figure 1-3B). In one of the most studied pathways, RPM-1 
forms an SCF-like ubiquitin ligase complex with the F-box protein FSN-1 (Liao et 
al., 2004). A major target of this complex is DLK-1, a component of a MAPK 
cascade (Nakata et al., 2005). RPM-1 also binds to GLO-4, a guanine exchange 
factor that regulates GLO-1, a Rab GTPase (Grill et al., 2007). Finally, RPM-1 
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was shown to bind to and function upstream of the microtubule binding protein 
RAE-1 (Grill et al., 2012). 
In order to identify novel molecules involved in rpm-1 signaling, I used a 
genetic as well as a biochemical approach. First, genetic and transgenic work 
suggested the existence of additional regulators of the dlk-1 MAP kinase 
cascade. Here I provide evidence that ppm-1, a serine/threonine phosphatase 
homologous to human PP2Ca(PPM1A) and PP2Cb(PPM1B) acts as a second 
negative regulatory mechanism to control the dlk-1 pathway. I show that ppm-1 
functions through its phosphatase activity in a parallel genetic pathway with glo-4 
and fsn-1 to regulate both synapse formation in the GABAergic motorneurons, 
and axon termination in the mechanosensory neurons. My transgenic analysis 
shows that ppm-1 acts downstream of rpm-1 to negatively regulate the dlk-1 
pathway, with ppm-1 most likely acting at the level of pmk-3. This study provides 
insight into the negative regulatory mechanisms that control the dlk-1 pathway in 
neurons, and demonstrates a new role for the PP2C/PPM phosphatases as 
regulators of neuronal development. 
In addition, this dissertation describes my work to characterize the novel 
RPM-1 binding protein ANC-1. I show that anc-1, like rpm-1, regulates axon 
termination and synapse formation. My genetic analysis also indicates that anc-1 
functions through the -catenin bar-1, and that the anc-1/bar-1 pathway functions 
cell autonomously, downstream of rpm-1 to regulate neuronal development. This 
study highlights a new role for ANC-1 in neuronal development and unveils a 
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new mechanism by which RPM-1 functions. Furthermore, my findings represent 
the first genetic link between RPM-1 and a pathway that is regulated by 
extracellular signals, such as Wnts. 
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2 PPM-1, a PP2C phosphatase, regulates axon termination 
and synapse formation in C. elegans 
 
Content adapted from published article: Tulgren ED, Baker ST, Rapp L, 
Gurney AM, Grill B (2011) PPM-1, a PP2Calpha/beta phosphatase, 
regulates axon termination and synapse formation in Caenorhabditis 
elegans. Genetics 189:1297-1307. 
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2.1 Introduction 
The Pam/Highwire/RPM-1 (PHR) proteins are key regulators of neuronal 
development that function in synapse formation, axon termination and guidance, 
axon regeneration, and glutamate receptor trafficking (Schaefer et al., 2000; Wan 
et al., 2000; Zhen et al., 2000; Burgess et al., 2004; D'Souza et al., 2005; 
Lewcock et al., 2007; Li et al., 2008a; Hammarlund et al., 2009; Park et al., 2009; 
Po et al.). The PHR protein family includes: human Pam, mouse Phr1, zebra fish 
esrom/Phr1, Drosophila Highwire and C. elegans Regulator of Presynaptic 
Morphology (RPM)-1.   
 PHR proteins function through multiple downstream signaling pathways. In 
C. elegans, RPM-1 functions as part of an ubiquitin ligase complex that includes 
the F-box protein, F-box Synaptic Protein (FSN)-1 (Liao et al., 2004). This 
complex negatively regulates a MAP kinase cascade that includes dual leucine 
zipper-bearing kinase (dlk-1), map kinase kinase (mkk)-4, p38 map kinase (pmk)-
3, map kinase activated protein kinase (mak)-2, and the transcription factor cebp-
1 (Nakata et al., 2005; Yan et al., 2009). Drosophila Highwire and mouse Phr1 
negatively regulate the ortholog of DLK-1 through a similar mechanism (Wu et 
al., 2007; Saiga et al., 2009; Tada et al., 2009; Nakata et al., 2005; Collins et al., 
2006; Lewcock et al., 2007). Phr1 also ubiquitinates and negatively regulates the 
Tuberin Sclerosis Complex (Murthy et al., 2004; D'Souza et al., 2005; Han et al., 
2008). RPM-1 positively regulates signaling through a Rab GTPase pathway by 
binding to Gut Granule Loss (GLO)-4 (Grill et al., 2007).  
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 While RPM-1 negatively regulates the DLK-1 pathway, there are a number 
of reasons to suspect that the DLK-1 pathway may also be controlled by other 
negative regulatory mechanisms. First, overexpression of dlk-1 causes more 
dramatic phenotypes than rpm-1 loss of function (lf), including uncoordinated 
movement and small body size (Nakata et al., 2005; Abrams et al., 2008). 
Second, the dlk-1 pathway consists of 5 signaling molecules providing numerous 
points where regulation might occur. Third, ubiquitination is a relatively slow 
acting mechanism to restrict DLK-1 signaling. The observation that UEV-3 is a 
possible positive regulator of PMK-3 (Trujillo et al., 2010) further supports the 
idea that multiple mechanisms may control the DLK-1 pathway.  
 There is a large body of evidence that MAP kinases are negatively 
regulated by phosphatases including MAP kinase-specific phosphatases, and 
broad acting PP2C/PPM family phosphatases (Lu and Wang, 2008; Shi, 2009; 
Bermudez et al.). While MAP kinases are known to function in neurons (Ji et al., 
2009; Samuels et al., 2009), the negative regulatory phosphatases that control 
MAP kinase signaling in neurons remain relatively poorly understood.  
 Here we provide evidence that neuronal development is regulated by a 
PP2C/PPM family phosphatase from C. elegans that we call protein phosphatase 
mg2+/mn2+ dependent (ppm)-1.  We have found that ppm-1 acts through its 
phosphatase activity to regulate axon termination and synapse formation by 
acting in a parallel genetic pathway to fsn-1 and glo-4. Loss of function in ppm-1 
is suppressed by loss of function in pmk-3 (p38 MAPK), suggesting that ppm-1 
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negatively regulates pmk-3 activity. This finding is consistent with our observation 
that ppm-1 functions downstream of rpm-1. Overall, our observations 
demonstrate that the DLK-1 pathway is negatively regulated by at least two 
mechanisms in neurons: the action of an SCF complex that includes RPM-1 and 
FSN-1, and the activity of a serine/threonine phosphatase, PPM-1.   
 
2.2 Results 
2.2.1 A PP2C phosphatase, PPM-1, regulates axon termination in the 
mechanosensory neurons of C. elegans. 
 
While the DLK-1 pathway is negatively regulated by RPM-1, several observations 
suggest that phosphatases of the PP2C/PPM family may also inhibit the DLK-1 
pathway. Biochemical experiments in vitro and in mammalian cell culture have 
shown that PP2C and (also called PPM1A and B) can dephosphorylate and 
negatively regulate MKKKs, MKKs, and MAPKs (Takekawa et al., 1998; Hanada 
et al., 2001). In yeast, the homologs of PP2C negatively regulate the activity of 
High-osmolarity glycerol (Hog)1, the homolog of p38 MAPK (Maeda et al., 1994; 
Jacoby et al., 1997; Nguyen and Shiozaki, 1999; Saito and Tatebayashi, 2004). 
Further, PP2C functions in mammalian neurons to control calcium flux (Li et al., 
2005) suggesting that PP2Cphosphatases may have undiscovered roles in 
neuronal development.  
 The C. elegans genome contains a single gene, temporarily assigned 
gene name (tag)-93 (F25D1.1), whose protein product is conserved with two 
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PP2C phosphatases in humans, PP2C/PPM1A and PP2C/PPM1B (49% 
identity and 69% conservation with PPM1A 54% identity and 72% conservation 
with PPM1B) (Stern et al., 2007) (Figure 2-1A and B). PP2C/PPM phosphatases 
are single subunit enzymes that require magnesium/manganese for activity, and 
consist of a catalytic domain and a regulatory domain (Lu and Wang, 2008; Shi, 
2009) (Figure 2-1B). Based on this homology, we have renamed tag-93 as 
protein phosphatase magnesium2+/manganese2+ dependent (ppm)-1. 
 There are three open reading frames of ppm-1 that are predicted in the C. 
elegans genome (F25D1.1a, F25D1.1b, and F25D1.1c) (www.wormbase.org). 
One of these open reading frames, F25D1.1c, encodes a 385 amino acid protein 
that has a conserved start site with mammalian PP2C/PPM1A (data not shown 
and Figure 2-1A and B). Using RT-PCR, we confirmed the coding sequence of 
F25D1.1c, and we used this transcript as our frame of reference for analysis of 
two alleles of ppm-1, ok578 and tm653. We sequenced the lesion in ok578 and 
found that it deletes 984 base pairs and inserts two thymidine bases, which 
causes a frameshift and leads to loss of wild-type sequence after amino acid 69. 
Importantly, ok578 deletes a residue (D246) that when mutated in mammalian 
PP2C/PPM1A results in a 4000-fold drop in phosphatase activity (Jackson et 
al., 2003) (Figure 2-1B). Sequencing of tm653 confirmed it has a 1089 base pair 
deletion in the ppm-1 gene that deletes a portion of the promoter, the start codon, 
and the first 156 amino acids of PPM-1 including a key catalytic residue (Figure 
2-1B). These observations show that ok578 and tm653 are molecular null alleles.  
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Figure 2-1. ppm-1 regulates axon termination in the ALM neurons.  
A) Shown is a schematic of the exons (hatched boxes) and introns of three open reading frames 
predicted for ppm-1 by wormbase. The deletions caused by ok578 and tm653 are shown below. 
B) A schematic of the human PP2Ca protein, and predicted PPM-1 proteins with the catalytic 
phosphatase domain (grey), and the regulatory domain (hatched design) highlighted. Shown 
below are segments of PPM-1 deleted by ok578 and tm653. Mutagenesis studies on human 
PP2Ca showed that mutation of residue D60 and D239 lead to 900 and 4000-fold decreases in 
phosphatase activity, respectively (Jackson et al., 2003). The corresponding conserved residues 
in PPM-1, D62 and D246 (F25D1.1c), are shown. C) Axon termination defects in the ALM 
mechanosensory neuron were visualized using muIs32[Pmec7GFP] for wild-type or the indicated 
mutant genotypes. Images correspond to the boxed region of the diagram. D) Quantitation of the 
total axon termination defects in ALM neurons.  E) Quantitation of specific, short hook (white) or 
big hook (grey), axon termination defects in the ALM neurons of the indicated genotypes. Note 
that the percentage of ALM axons that are normal/wild-type for each genotype is not shown. 
Scale bar is 10 mm. Error bars represent the standard error of the mean. Significance was 
determined using an unpaired t test . *p<0.05, ** p<0.01 
 
Defects in rpm-1 (lf) mutants are due, in part, to excess signaling through 
the dlk-1 pathway (Nakata et al., 2005; Grill et al., 2007; Trujillo et al., 2010). We 
hypothesized that ppm-1 (lf) might also increase signaling through the dlk-1 
pathway, and result in phenotypes that are similar to rpm-1 (lf) mutants. To test 
this hypothesis, we first analyzed the mechanosensory neurons of ppm-1 (lf) 
mutants.  
 In wild-type animals, the two ALM mechanosensory neurons each have a 
single axon that terminates at a precise location (Figure 2-1C). In contrast, axon 
termination is defective in the ALM neurons of rpm-1 (lf) mutants (Figure 2-1C 
and D). rpm-1 (lf) mutants display two types of ALM axon termination defects: 
less severe short hooks, and more severe big hooks where the axon overextends 
and hooks towards the posterior of the animal (Figure 2-1C and E). In rpm-1 (lf) 
mutants, big hooks in the ALM are the predominant phenotype, and this 
phenotype is temperature sensitive for the ju44 allele of rpm-1 (Figure 2-1E). In 
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ppm-1(ok578) and ppm-1(tm653) mutants, we observed small hook defects in 
the ALM neurons that occurred with low penetrance (Figure 2-1 C, D and E).   
 Previous studies showed that rpm-1 (lf) mutants also have defects in the 
PLM neurons which fall into two main phenotypic categories: 1) axon termination 
defects (Figure 2-2A) and 2) synaptic branch extension/stabilization defects 
(Figure 2-3A) (Schaefer et al., 2000; Grill et al., 2007). A given PLM neuron can 
display one or both of these phenotypes. In rpm-1 (lf) mutants, a small 
percentage of PLM axons (8%) display a milder axon termination phenotype in 
which the PLM axon only overextends beyond the ALM cell body (Figure 2-2A 
,overextension). The majority of PLM neurons in rpm-1 (lf) mutants (90%) display 
a more severe phenotype in which the PLM axon overextends beyond the ALM 
cell body and also hooks ventrally, which we will refer to as hooking for ease of 
discussion (Figure 2-2A hook). Both the hooking and synaptic branch defects in 
rpm-1 (lf) mutants are highly penetrant (Figure 2-2B and 2-3B). In ppm-1(ok578) 
mutants, we observed both axon termination phenotypes with a larger 
percentage of neurons showing the milder overextension phenotype, and a small 
percentage of neurons showing the more severe hooking phenotype (Figure 2-
2A and B). Similar results were obtained for ppm-1(tm653) (Figure 2-2B). With 
regard to synaptic branch extension, ppm-1(lf) animals had defects in synaptic 
branch extension that were very low penetrance (Figure 2-3A and B). These 
results show that ppm-1 regulates axon termination in the mechanosensory 
neurons. 
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Figure 2-2. ppm-1 regulates axon termination in the PLM neurons.  
A) Axon termination defects in the PLM neurons were visualized using muIs32[Pmec7GFP] for 
wild-type or the indicated mutant genotypes. Images correspond to the boxed region of the 
diagram. Arrows mark overextension of the PLM axon beyond the ALM cell body, and 
arrowheads mark the more severe phenotype of overextension and hooking of the PLM axon. B) 
Quantitation of the percentage of PLM neurons that only overextend (white), or overextend and 
hook (grey) for the indicated genotypes. Note that the percentage of PLM axons that are wild-type 
for each genotype is not shown. Analysis was performed on young adults grown at 23C, unless 
otherwise specified. Scale bar is 10 mm. Error bars represent the standard error of the mean. 
Significance was determined using an unpaired t test where n represents the number of 
independent counts of 10-30 worms for a given genotype. *** p<0.001, ns=not significant 
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2.2.2 ppm-1 functions in parallel to fsn-1 and glo-4 to regulate axon 
termination. 
rpm-1 has two major downstream signaling activities that are known. rpm-1 
functions with fsn-1 to negatively regulate the dlk-1 pathway (Liao et al., 2004), 
and binds to GLO-4 to positively regulate the glo pathway which includes: glo-4, 
glo-1 (a Rab GTPase), and apm-3 (Grill et al., 2007). To determine if ppm-1 
functions in either of these pathways or as part of an independent pathway, we 
constructed double mutants between ppm-1 and fsn-1, glo-4, and glo-1. When 
 
 
Figure 2-3. ppm-1 regulates synaptic branch extension/stabilization in PLM neurons.  
A) Defects in synaptic branch extension in the PLM neurons were visualized using 
muIs32[Pmec7GFP] in wild-type or the indicated mutant genotypes. Images correspond to the 
boxed region of the diagram.  The arrowhead highlights the absence of the synaptic branch. B) 
Quantitation of the defects in synaptic branch extension in the PLM neurons for the indicated 
genotypes. Note that the percentage of PLM axons that are wild-type for each genotype is not 
shown. Analysis was performed on young adults grown at 23C, unless otherwise specified. 
Scale bar is 10 mm. Error bars represent the standard error of the mean. Significance was 
determined using an unpaired t test where n represents the number of independent counts of 10-
30 worms for a given genotype. * p<0.05, *** p<0.001, ns=not significant 
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total mutant neurons were analyzed, fsn-1;ppm-1 double mutants had an additive 
phenotype in the ALM neurons (Figure 2-1B). However, an enhanced penetrance 
of big hooks was observed in fsn-1;ppm-1 double mutants compared to single 
mutants (Figure 2-1E). Both ppm-1(ok578) and ppm-1(tm653) had similar 
enhancer effects with fsn-1 (lf) (Figure 2-1E). While the level of big hooks was 
mildly increased in both glo-4,ppm-1 and glo-1;ppm-1 double mutants, these 
differences were not statistically significant demonstrating that ppm-1 does not 
enhance the glo pathway in the ALM neurons (Figure 2-1E).  
 With regard to the PLM neurons, fsn-1;ppm-1 double mutants had an 
enhanced percentage of neurons that show the hooking phenotype (Figure 2-
2B). The penetrance of synaptic branch defects was also strongly enhanced in 
fsn-1;ppm-1 double mutants (Figure 2-3B). Both alleles of ppm-1 (ok578 or 
tm653) gave similar levels of enhancement with fsn-1. The axon termination 
(hooking) and synaptic branch extension defects in the PLM neurons of glo-
4,ppm-1 double mutants were also enhanced (Figure 2-2B and 2-3B). In 
contrast, axon termination and branch extension defects in the PLM neurons of 
glo-1;ppm-1 double mutants and glo-1;fsn-1;ppm-1 triple mutants were 
increased, but not enhanced (Figure 2-2B and 2-3B). fsn-1;glo-4,ppm-1 triple 
mutants were not analyzed as fsn-1;glo-4 double mutants have maximal 
phenotypes (Figure 2-2B and 2-3B) (Grill et al., 2007). 
 To test if the two alleles of ppm-1 analyzed were null mutants, we 
performed transheterozygous analysis. With regard to the PLM neurons, fsn-
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1;ok578/tm653 mutants showed enhanced penetrance of defects in axon 
termination and synaptic branch extension (Figure 2-2B and 2-3B) that were not 
significantly different from fsn-1;ppm-1(ok578) and fsn-1;ppm-1(tm653) double 
mutants. These results are consistent with ok578 and tm653 acting as null alleles 
of ppm-1 in the PLM neurons. In the ALM neurons, fsn-1;ok578/tm653 had an 
increased percentage of neurons showing big hooks compared to fsn-1 single 
mutants, however levels were not increased to the same extent as fsn-1;ppm-
1(ok578) and fsn-1;ppm-1(tm653). Thus, in the ALM neurons the genes used as 
visible markers to generate fsn-1;ok578/tm653 animals (dpy-11 and unc-42) may 
affect ppm-1, or the ALM neurons may be less sensitive to ppm-1 loss of 
function. 
 Overall, our data are consistent with a model in which ppm-1 functions in a 
parallel pathway to fsn-1 and glo-4 to regulate axon termination and synaptic 
branch extension/stabilization in the PLM mechanosensory neurons. 
 
2.2.3 ppm-1 regulates synapse formation in GABAergic motor neurons. 
Previous studies have shown that rpm-1 regulates synapse formation in the 
motor neurons (Zhen et al., 2000; Nakata et al., 2005). The presynaptic terminals 
formed by the GABAergic DD motor neurons can be visualized with 
Synaptobrevin (SNB)-1 fused to GFP (GFP::SNB-1). In wild-type animals, 
GFP::SNB-1 puncta of the DD neurons are evenly distributed along the dorsal 
nerve cord (Figure 2-4A). In contrast, rpm-1 (lf) mutants have disorganized 
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GFP::SNB-1 puncta with gaps and aggregation (Figure 2-4A). While ppm-1 (lf) 
animals are normal, fsn-1;ppm-1 and glo-4,ppm-1 double mutants are enhanced 
with significant disorganization of GFP::SNB-1 puncta (Figure 2-4A) and reduced 
numbers of SNB-1::GFP puncta (Figure 2-4B). glo-1;ppm-1 double mutants had 
reduced numbers of SNB-1::GFP puncta, but defects were too mild to constitute 
enhancement (Figure 2-4B, p<0.05). We also observed that ppm-1,rpm-1 double 
mutants have similar defects as those in rpm-1 (lf) mutants. Importantly, synapse 
formation defects in rpm-1 (lf) mutants are not saturated, as defects become 
significantly worse in rpm-1;syd-2 double mutants (Liao et al., 2004). Therefore, 
our observations are consistent with ppm-1 regulating synapse formation by 
functioning in the same genetic pathway as rpm-1, and a parallel genetic 
pathway to fsn-1 and glo-4.  
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Figure 2-4. ppm-1 regulates synapse formation in GABAergic motor neurons.  
A) Presynaptic terminals of DD neurons were visualized using juIs1[Punc-25SNB-1::GFP] in wild-
type or mutant genotypes. Arrows highlight the gaps between presynaptic puncta in the dorsal 
cord. B) Quantitation of the average number of SNB-1::GFP puncta per 100m of dorsal cord. 
Analysis was performed on young adults grown at 25C. Scale bar is 10 mm. Significance was 
determined using a Student's t test, and error bars represent the standard error of the mean. *** 
p<0.001, ns = not significant. 
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2.2.4 ppm-1 functions in mechanosensory neurons downstream of rpm-1. 
rpm-1 and its downstream signaling molecules, glo-4 and glo-1, act cell 
autonomously in mechanosensory neurons (Schaefer et al., 2000; Grill et al., 
2007). To determine if ppm-1 functions cell autonomously, we performed 
transgenic rescue experiments in which ppm-1 expression was driven by 
different promoters. Transgenic expression of ppm-1 using either a fosmid 
(native ppm-1 promoter), Prgef-1 (a pan-neuronal promoter) or Pmec-7  (a 
mechanosensory neuron promoter) rescued PLM axon termination defects in 
both ppm-1 single mutants and fsn-1;ppm-1 double mutants (Figure 2-5A). 
Previous studies identified a single point mutation (D239N) that results in a 4000-
fold decrease in phosphatase activity in human PP2C (Jackson et al., 2003) 
(Figure 2-1A). ppm-1 that is mutated at the corresponding residue (D246N), and 
presumably catalytically inactive, did not rescue the enhanced axon termination 
defects in fsn-1;ppm-1 double mutants (Figure 2-5A). These results demonstrate 
that ppm-1 regulates axon termination through its phosphatase activity, and that 
the lesion in ok578 causes the enhanced penetrance of axon termination defects 
observed in ppm-1;fsn-1 double mutants. 
 Our genetic analysis described earlier indicates that ppm-1 functions in 
the same genetic pathway as rpm-1. To determine if ppm-1 functions up or 
downstream of rpm-1, we generated transgenic animals that overexpress PPM-1 
in the mechanosensory neurons of rpm-1 (lf) mutants. Overexpression of PPM-1 
strongly, but partially, reduced the axon termination defects in rpm-1 (lf) mutants 
(Figure 2-5B). In contrast, phosphatase-dead PPM-1 did not rescue axon 
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termination defects in rpm-1 (lf) mutants (Figure 2-5B). These results are 
consistent with ppm-1 functioning as a phosphatase that acts downstream of 
rpm-1. 
 
 
Figure 2-5 Transgenic expression of ppm-1 in the mechanosensory neurons rescues ppm-
1 (lf) defects in axon termination.  
A) Recue of axon termination defects in the PLM neurons of ppm-1 or fsn-1;ppm-1 mutants by 
transgenic expression of PPM-1 using the indicated promoters. The percentage of PLM axons 
that overextend only (white), or overextend and hook (grey) are shown. The percentage of PLM 
neurons with normal axon termination is not shown. For all transgenes, the data shown is from 
two to three transgenic lines, except for the fosmid wrm613bH10 (Exppm-1) in which only one 
transgenic line was analyzed. B) Axon termination defects in rpm-1 (lf) mutants are partially 
rescued by transgenic expression of PPM-1, but not by transgenic expression of phosphatase-
dead PPM-1 (D246N). The data shown is from 2-3 transgenic lines for each genotype. Analysis 
was performed on young adults grown at 23C. Error bars represent the standard error of the 
mean. Significance was determined using an unpaired t test where n represents the number of 
independent counts of 10-30 worms for a given genotype. *p<0.05, *** p<0.001 
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2.2.5 PPM-1 negatively regulates the DLK-1 pathway. 
Previous studies have shown that the orthologs of PPM-1 can act at the level of 
MKKK, MKK or MAPK to negatively regulate a kinase cascade (Takekawa et al., 
1998; Hanada et al., 2001). These observations suggested that phenotypes in 
ppm-1 (lf) mutants might be due to excess activation of dlk-1, mkk-4 and/or pmk-
3. To address this question, we employed two experimental strategies. First, we 
used a transgenic approach to test if ppm-1 negatively regulates the DLK-1 
pathway. Overexpression of DLK-1 resulted in similar severity and penetrance of 
phenotypes as those seen in rpm-1 (lf) mutants including axon termination 
defects in the ALM (Figure 2-6A) and PLM neurons (Figure 2-6B), and defects in 
synaptic branch extension in the PLM neurons (data not shown). Coexpression 
of PPM-1, but not phosphatase-dead PPM-1, partially rescued the defects 
caused by overexpression of DLK-1 (Figure 2-6A and B). This observation 
suggests that PPM-1 acts as a phosphatase to negatively regulate the DLK-1 
pathway.  
 Next, we used a genetic approach to determine which kinase in the DLK-1 
pathway might be a target of PPM-1's phosphatase activity. To do so, we 
constructed double mutants of ppm-1 with dlk-1, mkk-4, or pmk-3. Axon 
termination defects (overextension) in the PLM neurons were analyzed for 
double mutants and compared to ppm-1 (lf) single mutants. Defects in axon 
termination were not rescued in dlk-1;ppm-1 and mkk-4;ppm-1 double mutants 
(Figure 2-6C). In contrast, axon termination defects in pmk-3;ppm-1 double 
mutants were significantly reduced compared to ppm-1 (lf) single mutants (Figure 
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2-6C). These observations are consistent with excess pmk-3 function leading to 
axon termination defects in ppm-1 (lf) mutants. 
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Figure 2-6. ppm-1 negatively regulates the dlk-1 pathway.  
Transgenic expression of DLK-1 causes axon termination defects in A) ALM neurons, and B) 
PLM neurons, which is suppressed by coexpression of PPM-1, but not phosphatase-dead 
PPM-1 (D246N). The data shown is pooled from three or more transgenic lines, except the 
data for phosphatase-dead PPM-1, which is from a single transgenic line. The percentage of 
PLM axons that hook are shown. The percentage of PLM neurons that overextend or are wild-
type are not shown. C) Analysis of suppression of ppm-1 mutant phenotypes by loss of 
function in dlk-1, mkk-4 and pmk-3. Quantitation of axon termination defects (overextension 
only) in the indicated mutant genotypes. Note that only pmk-3-/-;ppm-1-/- mutant animals 
show a significant suppression of defects in axon termination. Analysis was performed on 
young adults grown at 23C. Error bars represent the standard error of the mean. Significance 
was determined using an unpaired t test where n represents the number of independent 
counts of 10-30 worms for a given genotype. *p<0.05, **<0.005, and *** p<0.001 
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2.2.6 PPM-1 localizes to the presynaptic terminals of motor neurons. 
Given that ppm-1 functions in neurons, we wanted to test if it is expressed in 
neurons. To address this question, we generated transgenic animals in which the 
3.7 kb promoter of ppm-1 drives expression of GFP.  Pppm-1::GFP is expressed 
in neurons of the nerve ring, and motor neurons of the ventral nerve cord (Figure 
2-7A). Since ppm-1 is expressed in motor neurons, we used a transgenic 
approach to study the subcellular distribution of PPM-1 in the GABAergic DD and 
VD motor neurons. We generated transgenic animals that express a fusion 
protein of mCherry and PPM-1, and a fusion protein of GFP and SNB-1, a 
synaptic vesicle membrane protein. SNB-1::GFP localizes to presynaptic puncta 
in the dorsal cord where the DD neurons innervate muscle (Figure 2-7B). While 
mCherry::PPM-1 was not always punctate, mCherry::PPM-1 puncta were 
observed in the dorsal cord and colocalized with GFP::SNB-1 (Figure 2-7B). 
These results demonstrate that PPM-1 can localize to the presynaptic terminals 
of GABAergic motor neurons. 
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2.3 Discussion 
RPM-1 functions as part of an E3 ubiquitin ligase/SCF complex that includes 
FSN-1. This complex ubiquitinates and destroys DLK-1 to negatively regulate a 
MAP kinase pathway (Nakata et al., 2005). RPM-1 is part of a conserved protein 
family called Pam/Highwire/RPM-1 (PHR) proteins, and PHR proteins in flies and 
 
 
Figure 2-7. PPM-1 is expressed in neurons and localizes to presynaptic terminals.  
A) Transgenic worms that use the 3.7 kb promoter of ppm-1 (F25D1.1) to express GFP were 
analyzed by epifluorescent microscopy. GFP is expressed broadly by the ppm-1 promoter 
(upper image), and is present in neurons of the ventral cord (arrows, lower left image), and the 
nerve ring (arrow, lower right image). B) Confocal microscopy was used to analyze transgenic 
worms that express mCherry::PPM-1 (red) and GFP::SNB-1 (green) specifically in the 
GABAergic motor neurons using the unc-25 promoter. mCherry::PPM-1 colocalizes with 
GFP::SNB-1 at presynaptic terminals in the dorsal nerve cord. 
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mice also function as part of SCF complexes to regulate synapse formation and 
neuronal development (Burgess et al., 2004; Collins et al., 2006; Lewcock et al., 
2007; Wu et al., 2007; Saiga et al., 2009; Tada et al., 2009). Thus, negative 
regulation of the DLK-1/Dlk pathway represents an essential, evolutionarily 
conserved function of the PHR proteins. While PHR proteins represent one 
mechanism for negatively regulating the DLK-1 pathway, it remains uncertain if 
other, complementary mechanisms also restrain the activity of this pathway. In 
the second chapter of this dissertation we provide evidence of a conserved 
PP2C phosphatase, PPM-1, that also negatively regulates the DLK-1 
pathway.  
 Our genetic analysis shows that loss of function in ppm-1 results in 
relatively mild phenotypes compared to rpm-1. This finding explains why ppm-
1mutants were not isolated in previous genetic screens for mutants with 
defective axon termination or synapse formation. We also show that ppm-1 (lf) 
enhances fsn-1 and glo-4 (lf). Our observations are consistent with ppm-1 
functioning in a genetic pathway that is parallel to both fsn-1 and glo-4. 
 With regard to axon termination in the PLM neurons, and synapse 
formation in the GABAergic motor neurons, we observed that glo-4,ppm-1 double 
mutants were enhanced, and glo-1;ppm-1 double mutants were not enhanced. 
This observation suggests that glo-4 plays a greater role in axon termination and 
synapse formation than glo-1. This interpretation is consistent with our 
observations that glo-4 has stronger enhancer effects than glo-1 with fsn-1 (Grill 
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et al., 2007) (Figure 2-4). Presumably a certain level of reduced GLO pathway 
function is needed to enhance ppm-1 (lf). While glo-4 (lf) achieves this level of 
inactivation of the GLO pathway, glo-1 does not. This model suggests that an 
unidentified small GTPase or signaling molecule, besides GLO-1, functions 
downstream of GLO-4. Presumably loss of function in both glo-1 and this other 
molecule(s) are required to enhance ppm-1 (lf).  
Our observation that ppm-1 (lf) does not enhance rpm-1 (lf) demonstrates 
that ppm-1 functions in the same genetic pathway as rpm-1. This is consistent 
with our transgenic experiments showing that ppm-1 functions downstream of 
rpm-1 to negatively regulate the DLK-1 pathway.  
Previous studies have suggested that the orthologs of PPM-1 may act at 
the level of MAPKKK, MAPKK, or MAPK to negatively regulate the kinase 
pathway (Takekawa et al., 1998; Hanada et al., 2001). Our data showing 
suppression of ppm-1 axon termination defects by pmk-3 (lf) suggests that PPM-
1 may negatively regulate PMK-3 directly by dephosphorylation. If this is the 
case, we may be able to detect this interaction using a biochemical approach. 
Studies have shown that mutations in a conserved residue of PP2C 
phosphatases reduce catalytic activity and cause the phosphatase to bind its 
target with increased affinity (Chin-Sang and Spence, 1996; Takekawa et al., 
1998). If when coimmunoprecipitated with PMK-3, mutant PPM-1 showed 
stronger binding than wild type PPM-1, it would suggest PPM-1 directly binds to  
PMK-3. This technique was previously used successfully for another PP2C 
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phosphatase in C. elegans (Baker and Grill, unpublished). Another experimental 
option would be to test for an interaction using a yeast two-hybrid assay. 
Alternatively, PPM-1 may negatively regulate a positive regulator of PMK-3, such 
as UEV-3. Genetic analysis of ppm-1;uev-3 mutants may reveal if this is the 
case. 
 It is not immediately clear to us why only pmk-3 (lf) suppresses ppm-1 (lf) 
defects. We anticipated that loss of function in any component of the DLK-1 
pathway would prevent activation of this pathway, and suppress phenotypes 
caused by ppm-1 (lf). One explanation for our results is that kinases other than 
DLK-1 and MKK-4 also function upstream of PMK-3, and suppression only 
occurs with loss of function in the target of PPM-1, presumably PMK-3. Mixed 
Lineage Kinase (MLK)-1, a MAP3K, was recently shown to function upstream of 
PMK-3 in the context of axon regeneration (Nix et al., 2011), and is a likely 
candidate as an alternative mechanism for activation of PMK-3 in the context of 
development. MLK-1 functions as part of another MAPK pathway consisting of 
the MAP2K MEK-1 and the JNK kinase KGB-1 (Nix et al., 2011), While the role 
of the MLK-1 pathway in development remains unknown, it is possible that PPM-
1 may also regulate this pathway. A genetic analysis of these kinases with ppm-1 
mutants may be informative. 
Importantly, the dlk-1 pathway is required not just in a developmental 
context, but also for axon regeneration in the mechanosensory neurons (Yan et 
al., 2009) and in the motor neurons of adult C. elegans (Hammarlund et al., 
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2009). Overexpression of dlk-1, or loss of function in rpm-1 or fsn-1 leads to 
improved axon regeneration (Hammarlund et al., 2009). Our discovery that ppm-
1 is a negative regulator of the dlk-1 pathway, similar to rpm-1 and fsn-1, 
suggests that ppm-1 may also function in axon regeneration. Given our finding 
that ppm-1 enhances fsn-1 with regard to defects in both axon termination and 
synapse formation, it is plausible that fsn-1;ppm-1 double mutants may also 
show enhanced increases in axon regeneration. Future experiments aimed at 
addressing this possibility will be informative, as PP2C phosphatase inhibitors 
could be a possible tool for improving neuron regeneration. While the PP2C 
phosphatases are resistant to traditional phosphatase inhibitors, a recent study 
has identified several compounds that appear to selectively inhibit PP2C 
(McConnell and Wadzinski, 2009). 
In summary, our study provides new insight into the molecular 
mechanisms of axon termination and synapse formation by showing that PPM-1 
constitutes a new regulatory mechanism to control signaling through the DLK-1 
pathway. Our study highlights the potential importance of the PP2C/PPM 
phosphatases in neuronal development. Addressing whether other members of 
the PP2C/PPM family function in axon termination and/or synapse formation 
remains an important goal for the future.  
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2.4 Materials and Methods 
Genetics 
C. elegans strains were maintained as described (Brenner, 1974). Alleles used in 
this study include: rpm-1(ju44), glo-1(zu391), fsn-1(hp1), ppm-1/tag-93(ok578), 
ppm-1/tag-93(tm653), dlk-1(ju476), mkk-4(ju91), and pmk-3(ok169). All double 
mutants were constructed following standard procedures, and were confirmed by 
the associated phenotypes or by PCR genotyping. glo-4,ppm-1 double mutants 
were constructed by recombination without using visible markers. Primers and 
PCR conditions are available upon request. fsn-1;ok578/tm653 animals were 
constructed using dpy-11 linked to ok578, and unc-42 linked to tm653. Non-dpy, 
non-unc animals with the genotype fsn-1;ok578,dpy-11/unc-42,tm653 were 
scored for trans-heterozygous analysis. The transgenic strains used in this study 
are: muIs32[Pmec-7GFP] (Ch'ng et al., 2003), juIs1[Punc-25SNB-1::GFP] (Hallam 
and Jin, 1998), bggEx35 [wrm613bH10], bggEx33 [Prgef-1::ppm-1 (cDNA 
F25D1.1c)], bggEx34, 40, and 41 [Pmec-7::ppm-1 (cDNA F25D1.1c)], bggEX58, 
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59, 60, 61, and 62 [Pmec-7::ppm-1 (D246N) (cDNA F25D1.1c)], bggEx55, 56 and 
57 [Pppm-1::GFP].  
  
Transgene Constructs 
To construct cell specific expression vectors of ppm-1, a ppm-1 cDNA 
(corresponding to the coding sequence of F25D1.1c.1) was amplified by RT-PCR 
from C. elegans RNA and cloned into the pCR8-Topo gateway entry vector 
(Invitrogen) to create pBG-GY146. pBG-GY146 was recombined into destination 
vectors containing the rgef-1 promoter, the mec-7 promoter or the myo-3 
promoter to generate pBG-GY153 (Prgef-1ppm-1), pBG-GY163 (Pmec-7ppm-1), and 
pBG-GY116 (Pmyo-3ppm-1). The D246N point mutant of PPM-1 was generated by 
site directed mutagenesis to create pBG-GY200 (pCR8 TopoGY ppm-1 (D246A). 
pBG-GY200 was recombined into destination vectors containing the mec-7 
promoter to generate pBG-GY202 (Pmec-7ppm-1 (D246N)). The fosmid 
wrm613bH10 and pBA183 (Pmyo-2mCherry) were gifts from Drs. David Greenstein 
(University of Minnesota) and Brian Ackley (University of Kansas), respectively. 
 Transgenic animals were generated as described previously (Mello et al., 
1991).  Plasmid DNA of interest was injected at 1-25ng/L along with Pttx-3RFP 
(50ng/L) or (Pmyo-2mCherry 1.5-2.5ng/L) and pBluescript (50ng/L). Initially all 
transgenic animals were generated on ppm-1-/- backgrounds. To create 
transgenic animals that were fsn-1;ppm-1 double mutants, fsn-1;ppm-1 mutants 
were heat shocked and males were mated to array positive ppm-1 mutants. For 
DLK-1 overexpression experiments, Prgef-1::dlk-1 was amplified by long PCR 
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using pBG-57 as a template and injected at 5-10ng/L. For rescue experiments 
with PPM-1, pBG-GY163 (Pmec-7::ppm-1) or pBG-GY202 (Pmec-7::ppm-1 
(D246N)) were coinjected at 2ng/L with Prgef-1::dlk-1. For analysis of PPM-1 
subcellular distribution, pBG-GY208 (Punc-25::mCherry-PPM-1) was injected at 
5ng/L into ppm-1(tm653);juIs1 animals. 
 
Axon termination and Synapse Formation Analysis  
Analysis was carried out using a Nikon epifluorescent microscope and a Q-
imaging camera at 40x magnification. Live animals were anesthetized using 1% 
(v/v) 1-phenoxy-2-propanol in M9 buffer. Axon termination defects were 
quantified by scoring 1-3 pools of worms consisting of 7-20 animals from 3 or 
more independent experiments for each genotype. The mean for a given 
phenotype was calculated and is shown in all histograms. All error bars represent 
the standard error of the mean. Statistical significance was calculated using an 
unpaired t test. For synapse formation defects, data was averaged from 20-30 
animals from a minimum of three independent experiments. The error bars 
represent the standard error of the mean, and statistical significance was 
determined using an unpaired t test. Results were considered significant for axon 
termination defects or synapse formation defects if a p value <0.05 was obtained. 
All analysis was done without blinding for genotypes. 
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3 The Nesprin family member ANC-1 regulates synapse 
formation and axon termination by functioning in a 
signaling pathway with RPM-1 and -Catenin 
 
Content adapted from: Tulgren ED, Turgeon SM, Opperman KJ, Grill B. 
The Nesprin family member ANC-1 regulates synapse formation and axon 
termination by functioning in a signaling pathway with RPM-1 and -
Catenin. (PLOS Genetics, under revision). 
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3.1 Introduction 
The mammalian Nuclear Envelope Spectrin repeat proteins (Nesprins) (also 
called Syne-1/Enaptin and Syne-2/NUANCE) mediate the anchorage of nuclei in 
multinucleated cells such as muscle (Zhang et al., 2007b; Puckelwartz et al., 
2009; Starr and Fridolfsson, 2010; Zhang et al., 2010; Mellad et al., 2011), and 
mediate nuclear movement and positioning in mononuclear cells (Zhang et al., 
2009; Luxton et al., 2010). The orthologs of Nesprin-1 and 2 are called MSP-300 
in Drosophila and abnormal nuclear Anchorage (ANC)-1 in C. elegans. MSP-300 
and ANC-1 also function in nuclear anchorage (Hedgecock and Thomson, 1982; 
Starr and Han, 2002; Zhang et al., 2002; Elhanany-Tamir et al., 2012), and 
regulate positioning of organelles including mitochondria and the endoplasmic 
reticulum (Starr and Han, 2002; Elhanany-Tamir et al., 2012).  
 Nesprin family members are attached to the nuclear envelope by the SUN 
proteins (SUN 1 and 2), which together compose the Linker of the 
Nucleoskeleton and Cytoskeleton (LINC) complex (Starr and Han, 2002; Zhen et 
al., 2002; Padmakumar et al., 2005; Lei et al., 2009; Starr and Fridolfsson, 2010; 
Mellad et al., 2011). A C-terminal Klarsicht/ANC-1/Nesprin homology (KASH) 
domain anchors Nesprin-1 and 2 in the outer nuclear membrane by binding to 
SUN1 and 2, which are localized to the inner nuclear membrane. C. elegans has 
two SUN family proteins: UNC-84 which is expressed in most somatic cells and 
retains ANC-1 in the nuclear membrane, and SUN-1 which functions in the germ 
line and early embryo. Tandem calponin homology domains at the N-terminus of 
the Nesprins mediate binding to the actin cytoskeleton. Nesprin-1, Nesprin-2 and 
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MSP-300 also anchor the nucleus to microtubules (Fan and Beck, 2004; Zhang 
et al., 2009; Schneider et al., 2011; Elhanany-Tamir et al., 2012).  
 Aside from their role in nuclear anchorage, Nesprin-1 and 2 have several 
other functions. Nesprin-1 and 2 regulate centrosome orientation in migrating 
cells and ciliogenesis (Dawe et al., 2009; Zhang et al., 2009; Luxton et al., 2010), 
regulate cytokinesis (Fan and Beck, 2004), and regulate formation and trafficking 
of the Golgi (Gough et al., 2003; Gough and Beck, 2004). Importantly, mutations 
in Nesprin-1 and 2 are associated with numerous diseases including: autism 
(O'Roak et al., 2011; Yu et al., 2013), cerebellar ataxia (Gros-Louis et al., 2007), 
Emery Dreifuss muscular dystrophy (Wheeler et al., 2007; Zhang et al., 2007a; 
Puckelwartz et al., 2009), cancer (Sjoblom et al., 2006; Tessema et al., 2008; 
Doherty et al., 2010), arthrogryposis (Attali et al., 2009), and cardiomyopathy 
(Puckelwartz et al., 2010). Genome-wide association studies have also identified 
single nucleotide polymorphisms in Nesprin-1 that are associated with 
schizophrenia (Lindholm et al., 2001; Andreassen et al., 2013) and bipolar 
disorder (Sklar, 2011; Andreassen et al., 2013; Green et al., 2013; Smoller et al., 
2013). 
 Nesprin-1 and 2 perform several functions at the neuromuscular junction 
(NMJ) and in the central nervous system (CNS). At the NMJ, multiple nuclei are 
anchored in clusters directly adjacent to the postsynaptic terminal. Nesprin-1 is 
enriched on these postsynaptic nuclei (Apel et al., 2000), and required for their 
clustering (Grady et al., 2005; Zhang et al., 2007b; Puckelwartz et al., 2009; 
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Zhang et al., 2010). Nesprin-1 is required for axon termination of motor neurons 
that innervate the diaphragm (Zhang et al., 2007b). Nesprin-1 and 2 are also 
expressed in neurons of the CNS (Apel et al., 2000; Padmakumar et al., 2004; 
Gros-Louis et al., 2007; Lein et al., 2007; Zhang et al., 2009), where they function 
in neuronal migration and neurogenesis by mediating connections between the 
nucleus and the cytoskeleton (Del Bene et al., 2008; Zhang et al., 2009). 
Nesprin-2 regulates nuclear positioning in photoreceptor cells (Tsujikawa et al., 
2007). Of particular note, Nesprin-1 shows extremely strong, broad expression in 
the adult murine CNS (Allen Brain Atlas: http://mouse.brain-map.org) (Lein et al., 
2007), which suggests that Nesprin-1 has an important function in neurons 
beyond its role in neural precursor migration and neurogenesis. This is consistent 
with the observation that a splice variant of Nesprin-1 called CPG2 regulates 
synaptic plasticity (Cottrell et al., 2004). A recent study in C. elegans showed that 
ANC-1 functions to maintain neural cell body position (Johnson and Kramer, 
2012). At present, it remains unclear if full length Nesprin-1 or its orthologs play 
broader roles in neuronal function and development outside of their roles in 
neural migration, neurogenesis, and maintenance of neuronal cell body position. 
 The role of Nesprin-1 and 2 in signal transduction has begun to be 
explored, but remains relatively poorly understood. In vascular smooth muscle 
cells, small isoforms of Nesprin-2 interact with Erk MAP kinase and regulate its 
signaling activity (Warren et al., 2010). Studies using a keratinocyte cell line 
showed that Nesprin-2 binds to - and ß-catenin, and regulates the nuclear 
   47 
localization of ß-catenin (Neumann et al., 2010). While these studies 
demonstrate that Nesprin-2 has the potential to regulate signal transduction, the 
broader functional consequences of these activities remain unclear. Further, it 
remains unknown if Nesprin-1 and/or Nesprin-2 mediate signal transduction in 
neurons. 
 Members of the Pam/Highwire/RPM-1 (PHR) protein family are large 
signaling proteins that include: human Pam (also called MYCBP2), murine Phr1, 
zebrafish Phr1 (Esrom), Drosophila Highwire, and C. elegans Regulator of 
Presynaptic Morphology (RPM)-1 (Fulga and Van Vactor, 2008; Po et al., 2010). 
The PHR proteins are important regulators of neuronal development that function 
in axon outgrowth and termination (Schaefer et al., 2000; Wan et al., 2000; Grill 
et al., 2007; Lewcock et al., 2007; Kim et al., 2013; Wang et al., 2013), axon 
guidance (D'Souza et al., 2005; Bloom et al., 2007; Li et al., 2008a; Shin and 
DiAntonio, 2011; Vo et al., 2011; James et al., 2013), and synapse formation 
(Wan et al., 2000; Zhen et al., 2000; Burgess et al., 2004; Bloom et al., 2007; 
Grill et al., 2007). C. elegans RPM-1 and Drosophila Highwire also function in 
axon regeneration (Hammarlund et al., 2009; Xiong et al., 2010; Nix et al., 2011) 
and axon degeneration following damage (Xiong et al., 2012). A recent study 
demonstrated an intriguing role for Highwire in aversive long-term memory 
(Huang et al., 2012). 
 The PHR proteins function through multiple mechanisms. Studies using 
worms, flies, fish and mice have shown that the PHR proteins act as E3 ubiquitin 
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ligases that negatively regulate p38 and JNK MAP kinase signaling by 
ubiquitinating the MAP3K Duel Leucine Zipper-bearing Kinase (Dlk) (called 
Wallenda in Drosophila and DLK-1 in C. elegans) (Nakata et al., 2005; Collins et 
al., 2006; Lewcock et al., 2007; Wang et al., 2013). Further, PHR proteins 
regulate vertebrate TOR signaling by ubiquitinating and negatively regulating the 
Tuberous Sclerosis Complex (Murthy et al., 2004; D'Souza et al., 2005; Han et 
al., 2008; Hendricks et al., 2008; Han et al., 2012). 
 The PHR proteins also have functions that are independent of their 
ubiquitin ligase activity. Studies in C. elegans have shown that RPM-1 positively 
regulates both a Rab GTPase pathway (Grill et al., 2007) and the mitotic 
regulatory protein RAE-1 (Grill et al., 2012b). Work in flies has also supported a 
role for Rae1 in Highwire function (Tian et al., 2011). Biochemical studies have 
shown that PHR proteins negatively regulate adenylate cyclase activity (Scholich 
et al., 2001), and bind to the transcription factor myc (Guo et al., 1998).  
 While the PHR proteins regulate several signal transduction pathways, it is 
poorly understood if their activities are linked to signaling by extracellular 
guidance cues, morphogens, or adhesion molecules. Work in Drosophila and C. 
elegans has shown that Highwire negatively regulates BMP signaling (McCabe et 
al., 2004), and RPM-1 negatively regulates Slit and Netrin signaling (Li et al., 
2008a). However, it is remains unclear if PHR protein activity converges with 
extracellular cues on common signaling targets. It is also uncertain if the PHR 
proteins have the ability to positively regulate, modify or enhance signals 
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generated by extracellular cues. The discovery of further molecular links between 
the PHR proteins and extracellular signals are likely to be helpful in 
understanding how PHR proteins facilitate axon extension, axon guidance, and 
synapse formation.  
  Using a proteomic approach in C. elegans, we have identified ANC-1 as 
an RPM-1 binding protein. Similar to rpm-1, anc-1 functions in both axon 
termination and synapse formation. Our analysis indicates that anc-1 functions in 
a genetic pathway with beta-catenin/armadillo related protein (bar)-1 downstream 
of rpm-1. Because BAR-1 is a component of canonical Wnt signaling pathways, 
our observations provide the first evidence of a link between RPM-1 signaling 
and morphogens that regulate neuronal development.  
 
3.2 Results 
3.2.1 Identification of ANC-1 as an RPM-1 binding protein. 
To better understand the mechanism of how RPM-1 functions in neuronal 
development, we previously performed a proteomic screen to identify RPM-1 
binding proteins (Grill et al., 2007). Briefly, RPM-1 fused with GFP was 
transgenically expressed using the native rpm-1 promoter. This construct was 
purified from whole worm lysate using an anti-GFP antibody, and RPM-1 binding 
proteins were identified using mass spectrometry and de novo peptide 
sequencing. To date, our screen has successfully identified three functional 
RPM-1 binding proteins: GLO-4 (a putative Rab GEF) (Grill et al., 2007), RAE-1 
(a microtubule binding protein) (Grill et al., 2007), and PPM-2 (a PP2C 
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phosphatase (Baker and Grill, unpublished observation). Our screen also 
identified the F-box protein FSN-1 (Grill et al., 2007), which was previously 
discovered using a genetic approach (Liao et al., 2004). Importantly, GLO-4, 
RAE-1 and PPM-2 are not targets of RPM-1’s ubiquitin ligase activity. Thus, our 
proteomic screen preferentially identifies RPM-1 binding proteins that are not 
degraded by RPM-1, and are stable interaction partners.  
 Another RPM-1 binding protein identified in our proteomic screen was 
ANC-1, a gigantic protein that is composed of 8545 amino acids and has an 
approximate molecular weight of 956 kDa. ANC-1 consists mostly of predicted 
coiled regions, including six repeats that are nearly identical at the nucleotide 
level (Figure 3-1A). The N-terminus contains dual calponin-homology (CH) 
domains which bind to actin (Korenbaum and Rivero, 2002; Starr and Han, 
2002), and the C-terminus consists of a KASH domain which targets ANC-1 to 
the nuclear envelope (Apel et al., 2000; Zhang et al., 2001; Starr and Han, 2002; 
Zhen et al., 2002). Previous work showed that ANC-1 is present at the nuclear 
envelope and in the cytoplasm of all post-embryonic somatic cells (Starr and 
Han, 2002).  
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 Our proteomic analysis identified 10 peptides that covered 6.3% of the 
total ANC-1 protein sequence (Data not shown). The majority of peptide 
sequence identified was from the ANC-1 specific repeats, presumably because 
repeat sequence is present at 6-fold molar excess over other regions of ANC-1. 
 
Figure 3-1 ANC-1 binds to RPM-1. 
(A) Schematic of ANC-1 protein structure which consists of two calponin homology (CH) 
domains that bind F-actin (dashed boxes), 6 repeat regions (grey), and a KASH domain 
(black) that mediates binding to the nucleus. Also shown is the C-terminal domain of ANC-1 
that functions as a dominant negative. (B) CoIP of endogenous ANC-1 with RPM-1::GFP. 
CoIPs were performed from whole worm lysates prepared from transgenic animals (juIs58) or 
non-transgenic animals (N2). (C) Epifluorescent microscopy was used to visualize SUR-
5::GFP in the multinucleated hypodermal cells of C. elegans. In wild-type animals, nuclei are 
anchored to the actin cytoskeleton and evenly spaced throughout the syncytium (arrowheads). 
In anc-1-/- mutants, impaired nuclear anchorage leads to aggregation of nuclei (arrows). Scale 
bar is 20mm. 
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To confirm the biochemical interaction between ANC-1 and RPM-1 we utilized 
coimmunoprecipitation from whole worm lysates generated from  transgenic 
animals. A prior study developed polyclonal anti-ANC-1 antibodies that recognize 
endogenous ANC-1, which was detected as multiple high molecular weight 
bands in immunoblots (Starr and Han, 2002). We used these anti-ANC-1 
antibodies in coimmunoprecipitation (coIP) experiments with transgenic animals 
expressing RPM-1::GFP (juIs58). When GFP::RPM-1 was immunoprecipitated 
using an anti-GFP antibody, coprecipitating ANC-1 was detected as multiple high 
molecular weight bands (Figure 3-1B, juIs58). Further examples of this coIP are 
shown in Figure 3-2. Coprecipitating bands were absent or strongly reduced in 
intensity in juIs58;anc-1-/- animals demonstrating that these bands represent 
endogenous ANC-1 (Figure 3-1B). Coprecipitating ANC-1 was not detected in 
precipitates from non-transgenic animals (Figure 3-1B, N2). Thus, ANC-1 did not 
bind to the agarose beads or the anti-GFP antibody demonstrating that the 
interaction between ANC-1 and RPM-1 was specific. These biochemical results 
confirm that RPM-1 binds to ANC-1 or a protein complex that contains ANC-1. 
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3.2.2 anc-1 regulates synapse formation in the GABAergic motor 
neurons. 
Previous studies have shown that rpm-1 regulates synapse formation in the 
GABAergic DD motor neurons (Zhen et al., 2000). The DD motor neurons 
innervate, and inhibit the dorsal muscles of the worm (Figure 3-3A schematic). 
The presynaptic terminals of DD neurons can be visualized in living animals 
using the transgene juIs1, which uses a cell specific promoter (Punc-25) to 
express a fusion protein of GFP and Synaptobrevin-1 (SNB-1::GFP) (Hallam and 
Jin, 1998). In wild type animals, SNB-1::GFP localized to evenly sized puncta 
that were uniformly positioned along the dorsal nerve cord (Figure 3-3A). In rpm-
 
 
Figure 3-2 Further examples of ANC-1 coIP with RPM-1 
Shown are two independent examples of endogenous ANC-1 coprecipitating with RPM-1::GFP 
from lysates of transgenic C. elegans. 
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1-/- mutants, SNB-1::GFP puncta in the dorsal nerve cord were abnormally 
aggregated (Figure 3-3A, arrowheads), and there were regions of the cord 
lacking any puncta (Figure 3-3A, arrows). Quantitation showed that the number 
of SNB-1::GFP puncta in rpm-1-/- mutants was significantly lower than wild-type 
animals (compare 11.9 +/- 0.4 SNB-1::GFP puncta/100m for rpm-1-/- to 21.9 +/- 
0.4 puncta/100m for wild type) (Figure 3-3B). These findings are consistent with 
results from previous studies (Zhen et al., 2000; Nakata et al., 2005; Tulgren et 
al., 2011; Grill et al., 2012). Importantly, previous electron microscopy studies 
showed that the defects in SNB-1::GFP puncta localization in rpm-1-/- mutants 
reflect defects in synapse formation, rather than defects in the formation of 
presynaptic terminals or the trafficking of synaptic vesicles (Zhen et al., 2000; 
Nakata et al., 2005). Subsequent studies have also shown that milder defects in 
organization of SNB-1::GFP puncta, such as those that occur in fsn-1-/- mutants, 
are also due to defects in both pre and postsynaptic terminals (Hung et al., 
2013).  
 Our observation that ANC-1 binds to RPM-1 led us to hypothesize that 
anc-1 might function in synapse formation similar to rpm-1. To test this 
hypothesis, we analyzed two alleles of anc-1, e1873 and e1753. DNA 
sequencing confirmed that e1873 is a nonsense mutation that results in a 
severely truncated protein (Figure 3-1A) (Starr and Han, 2002). The molecular 
nature of the lesion in e1753 remains unknown. However, a previous study 
showed that antibodies raised against the repeat region of ANC-1 fail to detect all 
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isoforms of ANC-1 greater than 175kDa in both anc-1(e1873) and anc-1(e1753) 
mutants (Starr and Han, 2002). These results suggest that e1873 and e1753 are 
likely to be molecular null alleles of anc-1.  
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Figure 3-3 anc-1 regulates synapse formation in the GABAergic motor neurons.  
(A) Upper panel diagrams the GABAergic DD neurons (blue) that innervate dorsal muscle. 
DD Presynaptic terminals are shown in green (modified from Worm Atlas). The red box 
highlights the region of the dorsal cord that was visualized by epifluorescent microscopy. The 
transgene juIs1 [Punc-25::SNB-1::GFP] was used to visualize the presynaptic terminals for 
the indicated genotypes. Arrows highlight regions lacking presynaptic terminals represented 
by SNB-1::GFP puncta. Arrowheads note abnormal aggregation of presynaptic terminals. 
Scale bar is 10µm. (B) Quantitation of the average number of SNB-1::GFP puncta per 100µm 
of dorsal cord. Analysis was done on young adults grown at 25°C. Significance was 
determined using an unpaired Student’s t test; error bars represent the standard error of the 
mean. ***P < 0.001, ns = not significant. 
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 Previous studies have shown that anc-1 loss of function (lf) results in 
abnormal nuclear anchorage (Anc) of the nuclei in the syncytial cells that form 
the hypodermis of C. elegans (Hedgecock and Thomson, 1982; Starr and Han, 
2002). The hypodermal nuclei can be visualized using a transgene, kuIs54, 
which expresses SUR-5::GFP (Yochem et al., 1998). In wild-type animals, the 
hypodermal nuclei are anchored to the cytoskeleton, and distributed in a well 
organized, even pattern (Figure 3-1C, arrowheads). Consistent with previous 
results, we observed that anc-1-/- animals display an Anc phenotype, in which 
the nuclei are no longer anchored and aggregate dramatically (Figure 3-1C, 
arrows).  
With regard to synapse formation, anc-1-/- mutants had normal spatial 
distribution and number of SNB-1::GFP puncta when analyzed qualitatively 
(Figure 3-3A) and quantitatively (Figure 3-3B). These results suggested that if 
anc-1 functions in synapse formation, it is likely to do so as a component of the 
rpm-1 pathway. To test this hypothesis, we constructed double mutants of anc-1 
with two rpm-1 pathway members, fsn-1 and glo-4. FSN-1 is an F-box protein 
that binds to RPM-1 and mediates RPM-1’s ubiquitin ligase activity (Liao et al., 
2004). GLO-4 binds to RPM-1, and is a putative guanine nucleotide exchange 
factor for a Rab pathway (Grill et al., 2007). We found that fsn-1-/-;anc-1-/- and 
glo-4-/-;anc-1-/- double mutants had enhanced defects in synapse formation 
compared to single mutants (compare 14.0 +/- 0.5 puncta/100m for fsn-1;anc-
1(e1873) to 18.3 +/- 0.3 for fsn-1) (Figure 3-3A and B). rpm-1-/-;anc-1-/- double 
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mutants had similar to defects to those observed in rpm-1-/- single mutants 
(Figure 3-3A and B). Additionally, we constructed rpm-1+/-;anc-1-/- mutants and 
found enhanced defects in synapse formation compared to rpm-1+/- animals 
(Figure 3-3A and B). These results are consistent with several conclusions. First, 
because we used null alleles, we conclude that anc-1 functions in a parallel 
genetic pathway to both fsn-1 and glo-4 to regulate synapse formation. Second, 
our observation that rpm-1-/-;anc-1-/- double mutants were not enhanced, in a 
phenotypic assay that is not saturated (Liao et al., 2004), suggests that anc-1 
functions in the same genetic pathway as rpm-1. This conclusion is further 
supported by our finding that rpm-1+/-;anc-1-/- double mutants had enhanced 
defects in synapse formation. Third, these results also support the conclusion 
that ANC-1 is not a target of RPM-1’s ubiquitin ligase activity. If this were the 
case, we would expect to see suppression of synapse formation defects in anc-1-
/-;rpm-1-/- double mutants similar to what was shown for DLK, a known target of 
RPM-1’s ubiquitin ligase activity (Nakata et al., 2005). 
 
3.2.3 The -catenin bar-1 functions in the same genetic pathway as anc-1 
to regulate synapse formation 
We next sought to dissect the mechanism of how anc-1 regulates synapse 
formation. A previous study found that Nesprin-2 (a mammalian ortholog of ANC-
1) regulates nuclear localization of -catenin, thereby potentially regulating Wnt 
signaling (Neumann et al., 2010). When Wnt signaling is not active, -catenin is 
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degraded. When Wnt signaling is activated, -catenin accumulates, enters the 
nucleus, and interacts with TCF/LEF family transcription factors to promote gene 
expression (Mosimann et al., 2009). Previous work in C. elegans has shown that 
Wnt signaling plays a prominent role in neuronal development (Forrester et al., 
2004; Pan et al., 2006; Prasad and Clark, 2006; Maro et al., 2009; Kirszenblat et 
al., 2011). In addition, lin-23 (an F-box protein that negatively regulates -catenin 
in C. elegans) regulates the abundance of postsynaptic glutamate receptors in 
the ventral nerve cord (Dreier et al., 2005), as well as axon termination in the 
ALM mechanosensory neurons (Mehta et al., 2004). Both of these 
developmental events are also regulated by rpm-1 (Schaefer et al., 2000; Grill et 
al., 2007; Park et al., 2009). Based on these studies, we hypothesized that anc-1 
may function as a genetic link between rpm-1 and the -catenin signaling 
pathway. 
 To test this hypothesis, we started by determining if -catenin regulates 
synapse formation in the DD motor neurons. In C. elegans, there are four -
catenins that have diverged to perform separate functions (Korswagen et al., 
2000; Natarajan et al., 2001; Liu et al., 2008; Phillips and Kimble, 2009; Jackson 
and Eisenmann, 2012). The canonical Wnt pathway operates through the -
catenin homolog BAR-1 (Korswagen et al., 2000; Natarajan et al., 2001) and a 
single TCF homolog, POP-1 (Lin et al., 1995; Thorpe et al., 1997). To test the 
role of bar-1 in synapse formation, we analyzed a null allele of bar-1, ga80 
(Eisenmann et al., 1998). While small, consistent sections of the dorsal cord 
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were absent in bar-1-/- mutants (data not shown), we were able to analyze 
synapse formation in sections of the dorsal cord that formed normally. bar-1-/- 
mutants showed a distribution and number of SNB-1::GFP puncta that were 
similar to wild-type animals (Figure 3-4A and B). However, fsn-1-/-;bar-1-/- 
double mutants showed enhanced defects in synapse formation compared to 
single mutants (compare 14.1 +/- 0.4 SNB-1::GFP puncta/100m for fsn-1;bar-1 
to 18.3 +/- 0.3 puncta/100m for fsn-1) (Figure 3-4A and B). The enhanced 
phenotype in fsn-1-/-;bar-1-/- double mutants was similar to what was observed 
for fsn-1-/-;anc-1-/- double mutants (Figure 3-3B and 3-4B), which suggested that 
anc-1 and bar-1 may function in the same genetic pathway. To test this 
possibility, we constructed double and triple mutants between bar-1, anc-1 and 
fsn-1. anc-1-/-;bar-1-/- double mutants were not enhanced compared to bar-1-/- 
and anc-1-/- single mutants (Figure 3-4A and B). Likewise, fsn-1-/-;anc-1-/-;bar-1-
/- triple mutants were not enhanced compared to fsn-1-/-;bar-1-/- or fsn-1-/-;anc-
1-/- double mutants (Figure 3-4A and B). 
   61 
 
To determine if BAR-1 regulates synapse formation by acting through a 
canonical signaling pathway that includes the TCF transcriptional factor POP-1, 
we analyzed the role of pop-1 in synapse formation. Because null alleles of pop-1 
are lethal, we opted to analyze a hypomorphic allele of pop-1, q645. The POP-1 
 
 
Figure 3-4 anc-1 and bar-1 function in the same genetic pathway to regulate synapse 
formation.  
(A) Epifluorescent microscopy was used to visualize presynaptic terminals labeled using the 
transgene juIs1 [Punc-25::SNB-1::GFP]  for the indicated genotypes. Arrows highlight regions 
lacking presynaptic terminals represented by SNB-1::GFP puncta.  Arrowheads note abnormal 
aggregation of presynaptic terminals. Scale bar is 10µm. (B) Quantitation of the average 
number of SNB-1::GFP puncta per 100µm of dorsal cord. Analysis was done on young adults 
grown at 25°C. Significance was determined using an unpaired Student’s t test; error bars 
represent the standard error of the mean. ***P < 0.001, ns = not significant. 
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protein produced by q645 shows reduced interaction with BAR-1 due to a 
mutation in the catenin binding domain (Siegfried and Kimble, 2002). Similar to 
our findings with bar-1, pop-1-/- animals were largely wild-type, but pop-1-/-;fsn-
1-/- double mutants had enhanced defects in synapse formation that were of 
similar severity to fsn-1-/-;bar-1-/- double mutants (compare 14.6 +/- 0.4 SNB-
1::GFP puncta/100m for pop-1;fsn-1 to 18.2 +/- 0.3 puncta/100m for fsn-1) 
(Figure 3-4A and B).  
 To determine if bar-1 functions in the same pathway as rpm-1, we 
constructed bar-1-/-;rpm-1-/- double mutants. We observed no change in the 
severity of synapse formation defects in bar-1-/-;rpm-1-/- double mutants 
compared to rpm-1-/- single mutants (Figure 3-4B).  
 As a whole, our results support several conclusions. First, anc-1, bar-1 
and rpm-1 function in the same genetic pathway to regulate synapse formation. 
Second, the anc-1/bar-1 pathway acts in parallel to fsn-1 to regulate synapse 
formation. Finally, bar-1 is likely to regulate synapse formation by functioning 
through a canonical Wnt signaling pathway that includes the TCF transcription 
factor pop-1.   
 
3.2.4 anc-1 regulates axon termination in the PLM mechanosensory 
neurons 
Previous work showed that rpm-1 regulates axon termination in the Posterior 
Lateral Microtubule (PLM) mechanosensory neurons (Schaefer et al., 2000). The 
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PLM neurons are an excellent system in which to study axon termination, as 
each PLM neuron extends a single axon that terminates extension at a precise 
anatomical location (Chalfie and Thomson, 1979; Du and Chalfie, 2001). In 
addition, these neurons are easily visualized using a transgene (muIs32) that 
expresses GFP specifically in the mechanosensory neurons (Ch'ng et al., 2003). 
 C. elegans contains two PLM neurons whose axons terminate extension 
prior to the cell body of another mechanosensory neuron, the Anterior Lateral 
Microtubule (ALM) neuron (Figure 3-5A, schematic). In rpm-1-/- mutants, the 
PLM axons fail to terminate extension properly and overgrow past the ALM cell 
body and hook towards the ventral side of the animal (Figure 3-5A) (Schaefer et 
al., 2000). This defect, which we refer to as “hooking”, is highly penetrant in rpm-
1-/- mutants (87.6 +/- 1.5%) (Figure 3-5B). 
To determine whether anc-1 also functions in axon termination, we 
analyzed anc-1-/- animals as well as double mutants of anc-1 and members of 
the rpm-1 signaling pathway. Both anc-1(e1873)-/- and anc-1(e1753)-/- showed 
hook defects (3.4 +/- 0.8% for anc-1(e1873) and 1.9 +/- 0.8% for anc-1(e1753)) 
that were significant compared to wild-type animals, but occurred with extremely 
low penetrance compared rpm-1-/- mutants (Figure 3-5B). fsn-1-/-;anc-1-/- 
double mutants showed enhanced penetrance of defects compared to single 
mutants (compare 33.2 +/- 2.4 for fsn-1;anc-1(e1873) and 27.5 +/- 4.6% for fsn-
1;anc-1(e1753) to 9.1 +/- 1.1% for fsn-1) (Figure 3-5B). Likewise, glo-4-/-; anc-1-
/- double mutants also showed enhanced penetrance of defects compared to 
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single mutants (compare 36.9 +/- 1.9% for glo-4;anc-1(e1873) to 17.7 +/- 4.3% 
for glo-4) (Figure 3-5B). These results demonstrate that anc-1 regulates axon 
termination by functioning in a parallel pathway to both fsn-1 and glo-4.  
We also analyzed rpm-1-/-;anc-1-/- double mutants, which had the same 
penetrance of defects as rpm-1-/- single mutants. This result suggests that anc-1 
functions in the same genetic pathway as rpm-1 (Figure 3-5B). Consistent with 
this conclusion, we observed enhanced axon termination defects in rpm-1+/-;anc-
1-/-  heterozygous animals (Figure 3-5B). 
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Figure 3-5 anc-1 functions cell autonomously to regulate axon termination in the PLM 
mechanosensory neurons.  
(A) Upper panel diagrams the mechanosensory neurons of C. elegans (modified from Worm 
Atlas). PLM neurons were visualized using muIs32 [Pmec7::GFP]. The black box indicates the 
region of the animal that is visualized by epifluorescent microscopy and shown on the right. 
Shown for the rpm-1-/- mutant is the PLM axon termination phenotype that we refer to as a 
hook defect (arrowhead). Scale bar is 10µm. (B) Quantitation of axon termination (hook) 
defects in PLM neurons for the indicated genotypes. (C) An ANC-1 dominant negative 
construct (ANC-1 DN) was expressed using a pan-neuronal promoter (Prgef-1) or a 
mechanosensory neuron specific promoter (Pmec-3) with the indicated genotypes. A full 
length ANC-1 rescue construct (Pmec-7::ANC-1) was expressed in anc-1-/-;fsn-1-/- double 
mutants. The data shown is an average of 4 or more transgenic lines for each genotype. 
Analysis was done on young adults grown at 23°C. Error bars represent standard error of the 
mean. Significance was determined using an unpaired Student’s t test.  * P<0.05, **P < 0.01, 
***P < 0.001, ns = not significant 
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Having established that anc-1 regulates axon termination by functioning in 
the same pathway as rpm-1, we wanted to test if anc-1 functions cell 
autonomously in PLM neurons to regulate axon termination. Our first approach 
was to transgenically overexpress a dominant negative fragment of ANC-1. 
Previous work by Starr and Han showed that a C-terminal fragment of ANC-1 
that contains the KASH domain (see Figure 3-1A, C-terminal domain aa 8200-
8546) acts as a dominant negative by blocking binding of endogenous ANC-1 to 
the SUN domain protein UNC-84, thereby preventing ANC-1 localization to the 
nuclear envelope (Starr and Han, 2002). We engineered fsn-1-/- mutants to 
transgenically express this dominant negative ANC-1 fragment using a pan-
neuronal promoter (Prgef-1), and observed increased penetrance of axon 
termination defects compared to transgenic animals that expressed only the rgef-
1 promoter (compare 44.9 +/- 4.6% for fsn-1 + Prgef-1::ANC-1 dominant negative 
to 8.9 +/- 2.6 % for fsn-1 + Prgef-1) (Figure 3-5C). Transgenic expression of 
dominant negative ANC-1 in wild-type animals did not give a significant 
phenotype (Figure 3-5C). Next, we generated transgenic fsn-1-/- mutants in 
which a promoter that is specifically expressed in the mechanosensory neurons 
(Pmec-3) was used to drive expression of dominant negative ANC-1. fsn-1-/- 
mutants carrying transgenic arrays expressing dominant negative ANC-1 showed 
increased penetrance of axon termination defects (38.8 +/- 3.3%) compared to 
fsn-1-/- mutants that transgenically expressed mCherry (17.9 +/- 2.5%) (Figure 3-
5C). Thus, transgenic expression of dominant negative ANC-1, specifically in the 
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mechanosensory neurons, enhances fsn-1 (lf). We also transgenically expressed 
an anc-1 mini-gene using another mechanosensory neuron specific promoter 
(Pmec-7) and observed a strong, partial rescue of the enhanced axon 
termination defects in fsn-1-/-;anc-1-/- double mutants (compare 20.5 +/- 1.9 %  
for fsn-1;anc-1 + Pmec-7::ANC-1 to 40.4 +/- 3.8 % for fsn-1;anc-1)  (Figure 3-
5C). These results demonstrate several conclusions. First, anc-1 functions cell 
autonomously in the mechanosensory neurons to regulate axon termination. 
Second, ANC-1 needs to be associated with the nuclear envelope via its C-
terminal KASH domain in order to regulate axon termination. Finally, the lesion in 
anc-1 causes the enhanced axon termination defects observed in fsn-1-/-;anc-1-
/- double mutants . 
 
3.2.5 bar-1 regulates axon termination in the PLM mechanosensory 
neurons 
Our genetic analysis indicated a role for bar-1 in synapse formation, and we next 
sought to determine if bar-1 also functions in axon termination of the PLM 
neurons, similar to anc-1. bar-1-/- mutants showed no defects in axon termination 
(Figure 3-6A). However, bar-1-/-;fsn-1-/- double mutants had enhanced 
penetrance of axon termination defects compared to fsn-1-/- single mutants 
(compare 25.8 +/- 2.5% for fsn-1;bar-1 to 9.1 +/- 1.1% for fsn-1) (Figure 3-6A). 
The level of enhancement was similar to what was observed in fsn-1-/-;anc-1-/- 
double mutants, which suggested that bar-1 might function in the same pathway 
as anc-1. To test this, we generated anc-1-/-;bar-1-/- double mutants and fsn-1-/-
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;anc-1-/-;bar-1-/- triple mutants. As shown in Figure 3-6A, anc-1-/-;bar-1-/- double 
mutants were not enhanced. Similarly, fsn-1-/-;anc-1-/-;bar-1-/- triple mutants 
were not enhanced compared to fsn-1-/-;bar-1-/- double mutants and fsn-1-/-
;anc-1-/- double mutants (Figure 3-6A). Thus, bar-1 and anc-1 regulate axon 
termination by functioning in the same genetic pathway. Given that BAR-1 
regulates the transcription factor POP-1, we also tested if pop-1 regulated axon 
termination. Similar to bar-1, pop-1-/- animals had axon termination defects that 
occurred with very low penetrance, and pop-1-/-;fsn-1-/- double mutants were 
enhanced compared to single mutants (compare 47.7 +/- 4.3% for pop-1;bar-1 to 
9.1 +/- 1.1% for fsn-1). Importantly, pop-1-/-;bar-/- double mutants were not 
enhanced consistent with pop-1 and bar-1 functioning in the same genetic 
pathway (Figure 3-6A). Thus, BAR-1 functions through POP-1 to regulate axon 
termination. 
To address if bar-1 and rpm-1 function in the same genetic pathway to 
regulate axon termination, we generated rpm-1-/-;bar-1-/- double mutants. As 
shown in Figure 3-6A, rpm-1-/-;bar-1-/- double mutants had similar penetrance of 
hook defects to rpm-1-/- single mutants.  
 Given that ANC-1 functions cell autonomously in the mechanosensory 
neurons, we also wanted to determine if BAR-1 functions cell autonomously. To 
do this, we generated fsn-1-/-;bar-1-/- double mutants that transgenically express 
BAR-1 using a cell specific promoter. We performed our analysis on fsn-1-/-;bar-
1-/- double mutants because the penetrance of axon termination defects was 
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much higher than in bar-1-/- single mutants. When BAR-1 was expressed using a 
mechanosensory neuron specific promoter (Pmec-7), the axon termination 
defects in fsn-1-/-;bar-1-/- double mutants were significantly reduced (compare 
29.6 +/- 3.1 % for fsn-1;bar-1 to 12.1 +/- 2.0 % for fsn-1;bar-1 + Pmec-7::BAR-1) 
(Figure 3-6C). 
 Overall, these findings support several conclusions. First, bar-1 regulates 
axon termination in the PLM mechanosensory neurons by functioning in the 
same genetic pathway as rpm-1, anc-1, and pop-1. Second, bar-1 functions in a 
parallel genetic pathway to fsn-1. Finally, bar-1 regulates axon termination by 
functioning cell autonomously in the PLM mechanosensory neurons. 
 
3.2.6 bar-1 functions downstream of anc-1 and rpm-1 to regulate axon 
termination 
Our genetic analysis indicated that rpm-1, anc-1 and bar-1 function in the same 
pathway. We next sought to determine whether bar-1 functions up or 
downstream of anc-1 and rpm-1. We chose to perform our epistasis analysis 
using bar-1 for two reasons. First, the existing knowledge of how BAR-1 
functions allowed the design and implementation of highly informative 
experiments. Second, a previous study in mammalian cells on Nesprin-2 and -
catenin (the orthologs of ANC-1 and BAR-1, respectively) suggested that bar-1 
might function downstream of anc-1 (Neumann et al., 2010). Therefore, axon 
termination defects caused by loss of function in rpm-1 and enhanced axon 
termination defects in fsn-1-/-;anc-1-/- double mutants might be due, in part, to 
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decreased bar-1 activity. If this model was correct, we anticipated that 
overexpression of bar-1 might suppress the axon termination defects caused by 
loss of function in rpm-1 and the enhanced axon termination defects in fsn-1-/-
;anc-1-/- double mutants. We choose to address this question using a genetic 
approach that utilized a loss of function mutation in apr-1, as toxicity prevented 
us from transgenically overexpressing BAR-1 at high levels. 
 APR-1 is the C. elegans ortholog of human Adenomatous Polyposis Coli 
(APC) (Rocheleau et al., 1997; Hoier et al., 2000). In the vertebrate canonical 
Wnt signaling pathway, APC forms a complex with the scaffold protein Axin and 
the kinase GSK3 to phosphorylate -catenin and target it for destruction 
(Mosimann et al., 2009; Clevers and Nusse, 2012). APR-1 interacts with the 
functional axin ortholog PRY-1, and has been shown to negatively regulate the -
catenin BAR-1 during vulva development and neuroblast (Q cell) migration 
(Gleason et al., 2002; Korswagen et al., 2002). Thus, APR-1 can negatively 
regulate BAR-1 signaling, and apr-1 mutants are likely to have increased levels 
of BAR-1 which is consistent with findings from other organisms on Wnt signaling 
and APC function.  
 Because the axon termination defects in anc-1-/- mutants occurred with 
relatively low penetrance, we chose to analyze fsn-1-/-;anc-1-/- double mutants, 
which have enhanced defects. As shown in Figure 3-6B, fsn-1-/-;anc-1-/-;apr-1-/- 
triple mutants had significantly reduced penetrance of hook defects (21.4 +/- 
1.9%) compared to fsn-1-/-; anc-1-/- double mutants (33.2 +/- 2.4%). Importantly, 
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fsn-1-/-;apr-1-/- double mutants did not show reduced penetrance of defects  
(Figure 3-6B). These results show that increased BAR-1 activity suppresses anc-
1 (lf), which is consistent with bar-1 functioning downstream of anc-1.  
 To test if bar-1 functions downstream of rpm-1 we took a similar genetic 
approach using apr-1. As shown in Figure 3-6B, rpm-1-/-;apr-1-/- double mutants 
showed suppressed penetrance of axon termination defects when compared to 
rpm-1-/- single mutants (compare 65.1 +/- 3.9% hook for rpm-1;apr-1 to 87.6 +/- 
1.5% for rpm-1). These results support the conclusion that bar-1 functions 
downstream of rpm-1. 
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Figure 3-6 bar-1 functions downstream of anc-1 and rpm-1 to regulate axon termination.  
Quantitation of axon termination defects (hook) in PLM neurons for the indicated genotypes 
using muIs32. (A) bar-1 and pop-1 analysis. (B) apr-1 analysis. (C) A cell specific promoter 
(Pmec-7) was used to transgenically express BAR-1. Analysis was done on young adults grown 
at 23°C. Error bars represent standard error of the mean. Significance was determined using an 
unpaired Student’s t test. **P < 0.01, ***P < 0.001, ns = not significant 
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3.2.7 unc-84 regulates axon termination 
Our observation that transgenic overexpression of the ANC-1 KASH domain in 
fsn-1-/- mutants results in enhanced axon termination defects suggested that 
ANC-1 needs to localize to the nuclear envelope in order to regulate axon 
termination (Figure 3-5C). To further support this concept, we examined the role 
of UNC-84 in axon termination. UNC-84 is a conserved SUN domain protein that 
is localized to the inner nuclear membrane. UNC-84 binds to ANC-1, thereby 
tethering ANC-1 in the nuclear envelope and mediating formation of the LINC 
complex (Malone et al., 1999; Starr and Han, 2002; Starr and Fridolfsson, 2010). 
Therefore, we hypothesized that if ANC-1 needs to be localized to the nuclear 
membrane to function in axon termination, then unc-84-/- mutants would have 
axon termination defects that were similar to anc-1-/- mutants. 
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  In unc-84-/- mutants we observed a very mild penetrance of hook defects, 
similar to anc-1-/- animals (Figure 3-7). fsn-1-/-;unc-84-/- double mutants had 
enhanced penetrance of defects compared to fsn-1-/- single mutants (compare 
24.9 +/- 3.1% hook for fsn-1;unc-84 to 9.1 +/- 1.1% for fsn-1) (Figure 3-7). In 
contrast, anc-1-/-;unc-84-/- double mutants did not show a significant increase in 
penetrance compared to single mutants (Figure 3-7). Likewise, the penetrance of 
defects in fsn-1-/-;anc-1-/-;unc-84-/- triple mutants was not increased compared 
to fsn-1-/-anc-1-/- and fsn-1-/-;unc-84-/- double mutants (Figure 3-7). While the 
unc-84 allele we used, e1410, is not a full null, it results in loss of function in the 
SUN domain of UNC-84, and has nuclear anchorage defects (Malone et al., 
 
 
Figure 3-7 anc-1 and unc-84 function in the same genetic pathway to regulate axon 
termination.  
Quantitation of axon termination defects (hook) in PLM neurons for the indicated genotypes 
using muIs32. Analysis was done on young adults grown at 23°C. Significance was 
determined using a Student’s t test; error bars represent the standard error of the mean.  ***P 
< 0.001, ns = not significant 
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1999). Previous studies have shown that the SUN domain of UNC-84 is required 
for recruitment of ANC-1 to the nuclear envelope (Starr and Han, 2002). Thus, 
unc-84(e1410) is predicted to lack nuclear localization of ANC-1. This is 
consistent with our genetic data showing that loss of function in unc-84 does not 
enhance loss of function in anc-1. Thus, we conclude that unc-84 regulates axon 
termination by functioning in the same genetic pathway as anc-1, and in a 
parallel pathway to fsn-1. Importantly, these findings also support the conclusion 
that ANC-1 regulates axon termination by functioning at the nuclear envelope. 
 
3.3 Discussion 
While the role of the Nesprins in nuclear positioning and movement is well 
established, mounting evidence has suggested additional roles for this protein 
family. High expression of Nesprin-1 in the adult brain, links to synaptic plasticity, 
and an association with neurological conditions suggest that the Nesprins may 
function in neuronal development. Here, we show that ANC-1 binds to the PHR 
protein RPM-1, a large signaling protein involved in numerous developmental 
events in neurons. Our genetic analysis indicates that ANC-1 functions cell 
autonomously to regulate axon termination in the mechanosensory neurons, and 
synapse formation in the GABAergic motor neurons. Importantly, we also show 
that ANC-1 functions by positively regulating BAR-1, the -catenin isoform that 
functions in canonical Wnt signaling (Figure 3-8). Our study reveals a novel role 
for ANC-1 in intracellular signaling and neuronal development. Importantly, we 
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have also identified the ANC-1/BAR-1 pathway as a new mechanism by which 
RPM-1, and possibly other PHR proteins, regulate axon termination and synapse 
formation.  
 
 
 
 
Figure 3-8 Summary of RPM-1 signaling through the ANC-1/BAR-1 pathway.  
Canonical Wnt signaling through Disheveled and APR-1, an APC ortholog, regulates the -
catenin BAR-1. In the absence of Wnt, APR-1 is active and inhibits BAR-1. In the presence of 
Wnt, APR-1 is inhibited and BAR-1 activity is increased. Higher levels of BAR-1 lead to 
increased activation of the transcription factor POP-1 (TCF/LEF). We have shown that RPM-1 
binds to ANC-1, and RPM-1 and ANC-1 function in the same pathway to positively regulate 
BAR-1 activity. RPM-1 and ANC-1 are likely to function in a protein complex at the nuclear 
envelope to regulate BAR-1. We propose two models of how RPM-1 and Wnt signaling may 
regulate BAR-1 activity. 1) Canonical Wnt signaling may act coordinately with RPM-1 and 
ANC-1 to regulate BAR-1. 2) Wnt may function through RPM-1 and ANC-1 as a novel, non-
canonical mechanism to regulate BAR-1. 
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ANC-1 mediates RPM-1’s function 
Our proteomic screen for RPM-1 binding proteins identified the nuclear 
anchorage protein ANC-1, which was confirmed using coimmunoprecipitation. 
Consistent with these findings, our genetic analysis indicated that anc-1 and rpm-
1 function in the same genetic pathway to regulate synapse formation in the 
GABAergic motor neurons and axon termination in the PLM mechanosensory 
neurons. Importantly, transgenic analysis indicated that anc-1 functions cell 
autonomously in the mechanosensory neurons to regulate axon termination, 
similar to rpm-1. Our observation that defects in anc-1-/-;rpm-1-/- double mutants 
were not suppressed also suggests that RPM-1 positively regulates ANC-1.  
 It is likely that anc-1 functions downstream of rpm-1 for two reasons. First, 
all other RPM-1 binding proteins identified in our proteomic screen function 
downstream of RPM-1 (Grill et al., 2007; Grill et al., 2012b) (Baker and Grill, 
unpublished observation). This is presumably because potential upstream 
regulators of RPM-1 signaling engage in more transient interactions that are 
difficult to detect using proteomics. Second, our genetic analysis showed that 
bar-1 functions downstream of anc-1 and rpm-1, and these three genes function 
in the same genetic pathway. Because bar-1 and anc-1 (lf) result in similar 
enhancer effects with fsn-1 (lf), and defects caused by rpm-1 (lf) are more 
penetrant, it is probable that anc-1, like bar-1, functions downstream of rpm-1.  
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 The PHR protein family is highly conserved with orthologs in Drosophila, 
zebrafish and mice (Po et al., 2010). To date, all of the proteins identified in our 
proteomic screen for RPM-1 binding proteins (including FSN-1, GLO-4, and 
RAE-1) are evolutionarily conserved (Grill et al., 2007; Grill et al., 2012b). 
Therefore, RPM-1 and its downstream signaling pathways are likely to function 
through conserved mechanisms. ANC-1 is also conserved with orthologs in 
Drosophila (Msp-300) and mammals (Nesprin-1 and 2). Thus, ANC-1’s function 
in axon termination and synapse formation during development is also likely to 
be conserved. This is supported by the observation that the branches of phrenic 
nerves in Nesprin-1-/- knockout mice are overgrown, suggesting possible 
termination defects (Zhang et al., 2007b). Further addressing if ANC-1’s role in 
axon and synapse development is evolutionarily conserved remains an important 
goal. 
 
ANC-1 functions through the β-catenin BAR-1 
Our genetic results showed that the β-catenin bar-1 functions in synapse 
formation in the GABAergic motor neurons, and axon termination in the 
mechanosensory neurons. While prior studies have shown that BAR-1 regulates 
axon extension (Maro et al., 2009) and glutamate receptor trafficking in motor 
neurons (Dreier et al., 2005), our results show that BAR-1 plays a more 
expansive role in neuronal development than originally thought. We also provide 
significant insight into the mechanism of how BAR-1 is regulated by showing that 
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a novel pathway containing RPM-1 and ANC-1 functions upstream of BAR-1. Our 
functional genetic and transgenic findings are consistent with a prior study on a 
keratinocyte cell line, which showed that Nesprin-2 regulates the nuclear 
localization of -catenin (Neumann et al., 2010). Our results do not rule out the 
possibility that ANC-1 regulates the ubiquitination or phosphorylation of BAR-1. 
We used epifluorescent microscopy to investigate if BAR-1::GFP localization to 
the nucleus was altered in anc-1-/- mutants, but found no obvious changes (data 
not shown). However, this was done using multicopy arrays, thus more sensitive 
methods may be required to detect such changes. One possibility would be to 
engineer a strain with a single copy insertion of BAR-1::GFP. The lower 
expression of BAR-1::GFP may allow us to visualize minor changes in nuclear 
BAR-1 levels. Also, a reporter construct has been developed which allows for the 
visualization of TCF/POP-1 activity in vivo. This reporter, known as POPTOP, 
contains several copies of a POP-1 binding site which drives the expression of 
the fluorescent protein mCherry (Green et al., 2008). If when expressed in 
neurons the level of fluorescence was diminished in anc-1 mutants, it would 
suggest POP-1/BAR-1 activity was being affected. 
In the canonical Wnt signaling pathway, BAR-1 activates POP-1 (the sole 
C. elegans TCF/LEF transcription factor) (Jackson and Eisenmann, 2012). Our 
observation that defects in axon termination and synapse formation were 
enhanced in both fsn-1-/-;pop-1-/- and fsn-1-/-;bar-1-/- double mutants, and that 
defects were not enhanced in pop-1-/-;bar-1-/- double mutants is consistent with 
   80 
bar-1 and pop-1 functioning in the same genetic pathway. Because fsn-1-/-;pop-
1-/- double mutants displayed more penetrant defects than fsn-1-/-;bar-1-/- 
double mutants, it is possible that another β-catenin may also function through 
POP-1 to regulate axon termination. HMP-2 is an unlikely candidate as it 
functions in a cadherin-catenin complex and does not act through POP-1 (Costa 
et al., 1998; Korswagen et al., 2000). SYS-1 or WRM-1 are more likely as they 
regulate transcriptional activation and nuclear export of POP-1, respectively 
(Rocheleau et al., 1997; Lo et al., 2004; Kidd et al., 2005). In the case of synapse 
formation in the GABAergic motor neurons the situation is simpler. Phenotypes 
were similar in fsn-1-/-;pop-1-/- and fsn-1-/-; bar-1-/- double mutants suggesting 
that only bar-1 is likely to regulate pop-1’s activity in synapse formation in 
GABAergic motor neurons. 
In vertebrate neurons, -catenin plays a broad and important role in 
neurons by regulating a range of processes including: neuronal differentiation 
(Zechner et al., 2003; Hirabayashi et al., 2004; Fang et al., 2013), synaptic 
vesicle assembly (Bamji et al., 2003; Sun et al., 2009; Sun and Bamji, 2011), 
dendrite morphogenesis and plasticity (Murase et al., 2002; Yu and Malenka, 
2003), axon extension (Votin et al., 2005; David et al., 2008), and axon 
arborization and targeting in retinal ganglion cells (RGC) (Elul et al., 2003). -
catenin also regulates the morphology of neuromuscular junctions (NMJ) and 
phrenic nerve growth (Li et al., 2008b). Notably similar to -catenin’s function, 
Phr1 regulates RGC axon arborization and targeting (D'Souza et al., 2005) and 
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NMJ morphology (Burgess et al., 2004; Bloom et al., 2007), and both Phr1 and 
Nesprin-1 regulate axon growth in phrenic nerves (Burgess et al., 2004; Zhang et 
al., 2007b). While these studies hinted at a possible functional link between PHR 
proteins, Nesprins and -catenin, our finding that RPM-1, ANC-1 and BAR-1 
function in the same pathway provides the first mechanistic explanation for these 
phenotypic relationships in mammals. Thus, the functional relationship between 
RPM-1, ANC-1 and BAR-1 is likely to be evolutionarily conserved. Further, our 
study outlines a signaling network that links two central and important regulators 
of neuronal development, the PHR proteins and -catenin, through the function 
of ANC-1. 
 
ANC-1 regulates axon termination by functioning at the nuclear envelope 
ANC-1 regulates nuclear anchorage by binding to the nuclear envelope via its C-
terminal KASH domain, and binding to the actin cytoskeleton via its N-terminal 
calponin homology domains (Starr and Han, 2002). The SUN domain protein 
UNC-84 mediates binding of ANC-1 to the nuclear envelope. Several of our 
findings demonstrate that ANC-1 needs to be anchored to the nuclear envelope 
in order to regulate axon termination. First, we found that transgenic 
overexpression of dominant negative ANC-1 which acts by inhibiting recruitment 
of endogenous ANC-1 to the nuclear envelope (Starr and Han, 2002), enhances 
the axon termination defects caused by fsn-1 (lf). Second, loss of function in 
either anc-1 or unc-84 enhances the axon termination defects caused by fsn-1 
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(lf). Finally, we observed that anc-1 and unc-84 function in the same genetic 
pathway to regulate axon termination. Collectively, these findings support the 
conclusion that ANC-1 regulates axon termination by functioning at the nuclear 
envelope. 
While our genetic results indicate that ANC-1 positively regulates BAR-1, 
how this occurs is not clear. In mammals, Nesprin-2 binds to a complex of a- and 
-catenin, thereby facilitating nuclear localization or inhibiting nuclear export of -
catenin (Neumann et al., 2010). Thus, RPM-1 may mediate formation of an ANC-
1/BAR-1 complex, thereby facilitating nuclear localization of BAR-1. Alternatively, 
binding of RPM-1 to ANC-1 (or an ANC-1 containing protein complex) may 
regulate ANC-1 mediated export of BAR-1 from the nucleus. Isoforms of Nesprin-
1 and Nesprin-2 bind to the nuclear membrane protein Emerin (Mislow et al., 
2002; Libotte et al., 2005; Wheeler et al., 2007), and Emerin regulates nuclear 
export of β-catenin (Markiewicz et al., 2006). It is possible that ANC-1 may 
interact with the C. elegans Emerin, EMR-1, to decrease nuclear export of β-
catenin, and thus positively regulate β-catenin signaling. Future genetic 
experiments analyzing anc-1; emr-1 and emr-1;fsn-1 double mutants may be 
helpful in addressing this possibility. If it EMR-1 is functioning with ANC-1, it 
would be expected to also function in a parallel pathway to fsn-1, and in the 
same genetic pathway as anc-1. 
Previous studies showed that RPM-1 is localized to the perisynaptic zone 
of presynaptic terminals (Zhen et al., 2000; Grill et al., 2007; Abrams et al., 
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2008). However, a transgenically expressed fusion protein of GFP and RPM-1 is 
also found at low levels in the cell body and excluded from the nucleus of motor 
neurons (Zhen et al., 2000) and the mechanosensory neurons (Opperman and 
Grill, unpublished). In addition, RPM-1 binds to RAE-1, a protein that localizes to 
the nuclear envelope as well as presynaptic terminals (Grill et al., 2012b). Our 
finding that ANC-1 binds to RPM-1, that both genes function in the same 
pathway, and that ANC-1 regulates axon termination by functioning at the 
nucleus suggest that RPM-1 may play a novel signaling role in the neuronal cell 
body, possibly at the nuclear envelope. This model is supported by 
immunohistochemistry in mammals, which showed that the rat ortholog of RPM-1 
(called MYCBP2 or Pam) is present in the cell bodies of neurons in the spinal 
cord and throughout the brain (Ehnert et al., 2004; Santos et al., 2006).  
 
Implications of RPM-1 signaling on Wnt function  
An emerging question is whether the PHR proteins, or the signaling pathways 
they control, are regulated or integrated with signals originating from outside the 
cell. Extracellular guidance cues, adhesion molecules and morphogens, such as 
Wnts, play roles in both axon guidance and synapse formation (Shen and 
Cowan, 2010). By showing that the -catenin BAR-1 functions downstream of 
RPM-1, we have provided the first link between RPM-1 and the canonical Wnt 
signaling pathway (Figure 3-8). It seems intuitive that RPM-1 may act 
coordinately with canonical Wnt signaling to regulate the activity of BAR-1, 
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possibly in a spatially or temporally sensitive manner. However, an alternative 
possibility is that RPM-1 itself may be regulated by components of a Wnt 
pathway, thereby acting as a novel secondary mechanism by which Wnts 
regulate β-catenin signaling. Future genetic experiments on different Wnts and 
Wnt receptors are likely to be helpful in differentiating between these models.  
 Wnts are expressed as shallow gradients in the CNS (Lyuksyutova et al., 
2003; Yoshikawa et al., 2003), and function in both axon guidance and synapse 
formation (Shen and Cowan, 2010; Budnik and Salinas, 2011; Hollis and Zou, 
2012b). At present, it is uncertain how shallow gradients of Wnts lead to strong 
effects on neuronal development. Our results suggest that the PHR proteins may 
potentiate -catenin activity, thereby sensitizing neurons to Wnt signaling and 
shallow gradients.  
 Outside of their role in development, Wnts and PHR proteins also regulate 
axon regeneration (Hammarlund et al., 2009; Xiong et al., 2010; Nix et al., 2011; 
Hollis and Zou, 2012a). The PHR proteins regulate regeneration primarily by 
acting on the MAP3K Dlk. Our developmental findings suggest that PHR protein 
signaling may also converge with Wnt signaling on -catenin to control axon 
regeneration.  
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3.4 Materials and Methods 
Genetics 
The N2 isolate of C. elegans was propagated using standard procedures 
(Brenner, 1974). Alleles used in this study included; anc-1(e1873), anc-1(e1753), 
apr-1(ok2970), pop-1(q645); fsn-1(gk429); glo-4(ok623),  rpm-1(ju44); bar-
1(ga80), unc-84(e1410). The strain MH1870, which contains the transgene 
kuIs54, and anc-1(e1873) were kind gifts from Dan Starr. All mutants were 
constructed using standard procedures, and were confirmed using PCR or by the 
associated phenotypes. All heterozygous analysis with rpm-1 was done by 
linking rpm-1(ju44) with dpy-11(e224) and balancing with unc-42(e270). Other 
homozygous alleles were isolated as necessary and non-dpy non-unc (rpm-1, 
dpy-11/unc-42) animals were scored. The transgenic strains used in this study 
were: muIs32 [Pmec-7GFP] and juIs1 [Punc-25SNB-1::GFP]. 
 
Axon termination and synapse formation 
Analysis was carried out on live animals at 40x magnification using a Nikon 
epifluorescent microscope and a Q-imaging camera. Animals were anesthetized 
using 1% (v/v) 1-phenoxy-2-propanol in M9 buffer.  Synapse formation defects 
were quantified by collecting images of juIs1 (Punc-25::SNB-1::GFP) and 
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manually scoring puncta numbers in Adobe Photoshop. Dorsal cord lengths were 
determined in meters using Q-imaging software. Both bar-1-/- and pop-1-/- 
animals displayed reproducible gaps in their dorsal cord at stereotypical 
locations. Care was taken to avoid collecting images at these areas. Axon 
termination defects were visualized using muIs32 (Pmec-7::GFP) and manually 
scored.  
 
Transgenics 
Transgenic animals were generated using standard microinjection procedures.  
Transgenes were constructed by injection of plasmid DNA or DNA generated by 
PCR with Pttx-3RFP (50 ng/L) and pBluescript (50 ng/L).  Dominant negative 
ANC-1 was cloned as a genomic fragment (36523-37778). For rgef-1 promoter 
lines, the plasmid pBG-GY360 was amplified by PCR and injected at 10 ng/L. 
For the mec-3 promoter lines, the plasmid pBG-GY370 was amplified by PCR 
and injected at 5 ng/L.  The anc-1 mini-gene was constructed by ligating 
together 4 fragments: a cDNA fragment from 1-4154 bp using an engineered 
ApaI site and BamHI, a BamHI to NotI genomic fragment (14,808-24,000), a NotI 
to KpnI genomic fragment (24,001-36,849), and a KpnI to 3’ UTR fragment 
containing an engineered SacII site (36,850-38,921). Plasmid encoding the Pmec-
7ANC-1 (mini-gene, pBG161) was injected at 40 ng/L for anc-1-/- rescue. 
Plasmid encoding Pmec-7BAR-1 (genomic clone, pBG-GY318) was injected at 1 
ng/L for bar-1-/- rescue.  
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Biochemistry. 
Proteomic analysis of RPM-1 binding proteins, including ANC-1, was described 
previously (Grill et al., 2007).  For biochemical analysis of RPM-1 binding to 
ANC-1, worms were grown in liquid culture, harvested by centrifugation, frozen in 
liquid N2, ground with a mortar and pestle under liquid N2, and extracted using 
0.1% NP-40 lysis buffer as described previously (Grill et al., 2007). CoIPs were 
performed from 40 mg of total protein extract. RPM-1::GFP was precipitated 
using a mouse monoclonal antibody (3E6, MP Biomedical) and protein G 
agarose beads (Roche). For immunoblotting, precipitates were run on an SDS-
PAGE gel (3-8% Tris Acetate, Invitrogen), and proteins were wet transferred to 
PVDF membrane in Tris acetate transfer buffer (30 volts for 24-30 hours). Blots 
were blocked with part-skim milk in TBST, and probed with an anti-GFP antibody 
(mouse monoclonal, Roche) or purified anti-ANC-1 polyclonal antibodies that 
were used previously (Starr and Han, 2002). Primary antibodies were detected 
with secondary antibodies coupled to HRP, Supersignal FemtoWest enhanced 
chemiluminescent reagent (Pierce), and autoradiography.  
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4 Conclusion 
4.1 Future Directions 
4.1.1 emr-1 
While I have shown a genetic link between anc-1 and bar-1, the question still 
remains as to the mechanism of how ANC-1 actually regulates BAR-1 signaling. 
Recent studies have shown that the inner nuclear membrane protein emerin 
negatively regulates -catenin by restricting its accumulation in the nucleus. 
(Markiewicz et al., 2006). Cells transfected with emerin show lower levels of -
catenin in the nucleus as well as decreased TCF target gene activation. In 
addition, treatment with the CRM1 dependent nuclear export inhibitor leptomycin 
lead to increases in the amount of nuclear -catenin in emerin transfected cells, 
suggesting emerin participates in the nuclear export of -catenin. Isoforms of 
Nesprin-1 (Nesprin-1) and Nesprin-2 (Nesprin-2) have also been shown to 
bind emerin (Mislow et al., 2002; Libotte et al., 2005). Furthermore, the Nesprins 
bind to emerin in the same region known to bind -catenin (Wheeler et al., 2007). 
Thus anc-1 may antagonize the ability of emerin to export -catenin. This could 
be by competing with BAR-1 for binding to emerin, or perhaps by preventing 
emerin from forming a protein complex required for its -catenin export activity. 
This model is summarized in Figure 4-1. 
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To test this model, I have begun constructing and analyzing mutants for 
the C. elegans emerin emr-1. My model predicts that ANC-1 functions as a 
negative regulator of EMR-1; thus the phenotype observed in anc-1 mutants may 
 
 
Figure 4-1 anc-1 regulates the nuclear export of bar-1 via emr-1. 
Canonical Wnt signaling through Disheveled and APR-1, an APC ortholog, regulates the -
catenin BAR-1. In the absence of Wnt, APR-1 is active and inhibits BAR-1. In the presence 
of Wnt, APR-1 is inhibited and BAR-1 activity is increased. Higher levels of BAR-1 lead to 
increased activation of the transcription factor POP-1 (TCF/LEF). I have shown that RPM-1 
binds to ANC-1, and RPM-1 and ANC-1 function in the same pathway to positively regulate 
BAR-1 activity. I propose that the nuclear envelope protein EMR-1 functions to increase the 
export of BAR-1 from the nucleus, thereby decreasing nuclear levels of BAR-1 and 
decreasing POP-1 activation. RPM-1 and ANC-1 function as a complex to negatively 
regulate the nuclear export activity of EMR-1, resulting in decreased BAR-1 export and 
increased POP-1 activation.     
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be due in part to over activation of emr-1. Therefore mutations in emr-1 may 
suppress the axon termination defects found in anc-1 mutants. anc-1 mutants 
alone have a very low penetrance of termination defects; thus observing 
suppression is unlikely. However I do observe suppression of axon termination 
defects in the enhanced anc-1;fsn-1 double mutants when constructed with emr-
1, consistent with my model (Figure 4-2). 
 
To further examine the role of emr-1 in the rpm-1/anc-1 pathway, I also 
plan to construct emr-1;rpm-1 double mutants and analyze them for defects in 
axon termination. If my model is correct, I would expect to see a decreased 
 
 
Figure 4-2 emr-1 regulates axon termination in the PLM mechanosensory neurons. 
Quantitation of axon termination (hook) defects in PLM neurons for the indicated genotypes. 
Analysis was done on young adults grown at 23°C. Error bars represent standard error of the 
mean. Significance was determined using an unpaired Student’s t test.  **P < 0.01,  
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penetrance of PLM hooks when compared to rpm-1 mutants alone, similar to 
what I have shown in apr-1;rpm-1 double mutants. Also, co-immunoprecipitation 
could be used to determine whether ANC-1 and EMR-1 bind. If they are found to 
bind, using varying genetic backgrounds may indicate whether ANC-1 and BAR-
1 compete for binding to EMR-1. If ANC-1 and BAR-1 do compete for binding, I 
may see increased ANC-1 EMR-1 binding in a bar-1 mutant due to the loss of 
bar-1, while an apr-1 mutant background may show decreased ANC-1 EMR-1 
binding due to an overabundance of BAR-1. 
 
4.1.2 Role of Wnts in axon termination 
My findings suggest that RPM-1/ANC-1 may act coordinately with the canonical 
Wnt signaling pathway to regulate the activity of BAR-1 and POP-1. Thus RPM-1 
may fine tune or potentiate Wnt signals to regulate neurodevelopment. To 
investigate this possibility, I plan to construct mutants of the Wnt ligands and 
analyze them for PLM axon termination defects as well as look for genetic 
interactions with the rpm-1 pathway. Because the PLM projects its axon towards 
the anterior of the worm, a possible model of Wnt signaling in PLM axon 
termination is that the PLM axon grows until it reaches a repulsive Wnt cue, 
which signals the axon to terminate growth. This model is supported by the 
finding that Wnts expressed in the tail of C. elegans are required to orient the 
growth of the PLM axon towards the anterior of the worm (Hilliard and Bargmann, 
2006; Prasad and Clark, 2006). 
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The C. elegans genome encodes five Wnt ligands: lin-44, egl-20, mom-2, 
cwn-1, and cwn-2 (Shackleford et al., 1993; Herman et al., 1995; Rocheleau et 
al., 1997; Thorpe et al., 1997; Maloof et al., 1999). Of these Wnts, only cwn-2 is 
expressed highly in the anterior of the worm, making it the most likely candidate 
to mediate axon termination in the PLM neuron (Herman et al., 1995; Coudreuse 
et al., 2006; Song et al., 2010). My model predicts that as the PLM process 
grows, it encounters a gradient of CWN-2 that eventually leads to activation of 
the bar-1/pop-1 pathway and subsequent termination of growth. If my model is 
correct, I hypothesize that mutants lacking cwn-2 should display axon termination 
defects. In addition, my anc-1 data suggests that anc-1 and rpm-1 may function 
in parallel to cwn-2 to regulate activation of bar-1/pop-1, therefore cwn-2 may 
enhance axon termination defects of rpm-1 and anc-1 mutants. 
Besides cwn-2, cwn-1 and egl-20 are also possible regulators of PLM 
axon termination. Both cwn-1 and egl-20 function in establishing axon growth 
polarity in the ALM mechanosensory neuron (Prasad and Clark, 2006). The cell 
body of the ALM neuron is located in close proximity to the PLM axon termination 
point, indicating that these Wnts are present and functional in this area of the 
worm. 
 
4.1.3 Upstream regulators of rpm-1 
While genetic and proteomic approaches have been successful in identifying new 
molecules that function downstream of RPM-1, little is known about how the PHR 
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proteins themselves are regulated. If the PHR proteins do indeed act as a 
molecular switch to transition neurons from one stage of growth to the next, it 
would be predicted that they are under precise spatial and temporal regulation. 
What molecules mediate this regulation is unknown. Thus an important goal for 
future research is to identify the molecules/pathway that regulate PHR protein 
activity. In an attempt to answer this question, I have begun a biased genetic 
screen to identify molecules that function upstream of rpm-1. Although I am still 
in the early stages, several promising molecules have already been identified. 
 
4.2 Summary 
The formation of the nervous system depends on the creation of synapses. While 
it is clear that a number of events must be coordinated to form functional 
synapses, the molecular mechanism of how this occurs is unclear. The PHR 
proteins function in axon guidance (D'Souza et al., 2005; Lewcock et al., 2007; Li 
et al., 2008a), axon termination (Schaefer et al., 2000; Lewcock et al., 2007), and 
synapse formation (Schaefer et al., 2000; Wan et al., 2000; Zhen et al., 2000; 
Bloom et al., 2007). Thus the PHR proteins may function as molecules that can 
coordinate and integrate events during neurodevelopment. Understanding how 
the PHR proteins function and how their signaling pathways are regulated brings 
us one step close to understanding how a synapse is created. In this dissertation, 
my studies provide evidence that two molecules, PPM-1 and ANC-1, function in 
the RPM signaling pathway (Figure 4-3). 
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 In chapter 2, I provide evidence that the serine/threonine phosphatase 
ppm-1 functions as an additional regulatory mechanism for the dlk-1 pathway. I 
show that the phosphatase activity of ppm-1 is required for this regulation and 
that the most likely target is the p38 MAPK PMK-3. My work demonstrates a 
novel role for this family of proteins in neurodevelopment as well as a new 
mechanism for regulating the dlk-1 MAPK cascade in neurons. 
 In chapter 3, I show that the nuclear anchorage proteins ANC-1 binds to 
RPM-1. I find that anc-1 functions in the rpm-1 pathway to regulate axon 
 
 
Figure 4-3 ppm-1 and anc-1, two novel rpm-1 pathway components.  
The serine/threonine phosphatase ppm-1 functions parallel to fsn-1 and downstream of rpm-1 
to regulate the dlk-1 pathway. ppm-1 likely functions at the level of PMK-3. The nuclear 
anchorage protein ANC-1 binds to RPM-1 and functions in the regulation of synapse formation 
and axon termination. My genetic data also suggests that anc-1 functions in the same genetic 
pathway as the -catenin bar-1. 
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termination as well as synapse formation. Furthermore, my genetic analysis 
indicates anc-1 functions through the -catenin bar-1. This study provides a new 
mechanism by which RPM-1 functions, as well as describing a novel role for 
ANC-1 in neurodevelopment. 
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